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Clinical Decision-Making in Aphasia Therapy:  
A Survey of Percieved Levels of Evidence for Common Treatment Approaches 
 
Erin T. Rowe, B.S. 
 
ABSTRACT 
 
The past three decades have produced a surge of interest in the role of evidence-
based practice (EBP) in the clinical decision-making of speech-language pathologists and 
other healthcare professionals in delivering optimally effective patient care.  A review of 
the literature revealed several studies investigating potential barriers to EBP 
implementation and attitudes toward EBP.  However, few studies have been designed to 
probe what treatment approaches to neurogenic communication disorders clinicians are 
currently implementing and the rationales behind their use.  Furthermore, a review of the 
literature failed to reveal any surveys designed to probe the correlation between what 
clinicians perceive to be evidence based and what truly is evidence based as outlined in 
current practice guidelines.  The primary aim of this study was to examine potential 
trends within the field of speech-language pathology relating to the role of EBP in the 
clinical decision-making of aphasia therapy and the quality of evidentiary support for 
these decisions.  Launching both Web-based and hard copy versions of an 18-question 
survey, questions probed clinicians’ perceptions of the evidence level, primary sources of 
information, and timeframe of implementation related to various traditional treatment 
xi 
 
approaches for aphasia.  Analysis of the 104 survey responses revealed a disconnect 
between the implementation of aphasia treatments and the research behind their use.  
Results indicate that many of the common treatment approaches for aphasia currently in 
practice are evidence based.  However, a research-to-practice gap exists as many 
treatment approaches that clinicians are not reportedly using are also supported by 
evidence.  Similarly, clinicians’ perceptions of what is evidence based are not always in 
accordance with current practice guidelines.  Clinicians appear to rely on professional 
journals, graduate school training, and professional conferences as their primary sources 
of evidence-based information.  It does not appear as though advertising significantly 
affects clinicians’ decision making in treatment selection.  Furthermore, clinicians tend to 
implement new or alternative treatment approaches rather quickly after exposure to the 
treatment.  Although participants reportedly acknowledge the importance of EBP, further 
research is needed to investigate causes of and ways to eliminate the research-to-practice 
gap in the treatment of neurological communication disorders.   
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CHAPTER ONE: 
INTRODUCTION 
Evolution of Evidence-Based Practice 
 The evidence-based practice (EBP) paradigm, originating in the field of medicine 
as evidence-based medicine (EBM), is now used in a variety of disciples and 
rehabilitation fields.  Although scientific research had previously been used to guide 
clinical decision making prior to healthcare professionals recognizing the importance of 
an explicit EBP model, interest in EBP has increased significantly in the past three 
decades (Zipoli & Kennedy, 2005).  EBP can now be found within the literature in the 
fields of medicine (e.g., McAlister, Graham, Karr, Laupacis, 1999), speech-language 
pathology (e.g., Dollaghan, 2004), physical therapy (e.g., Connolly, Lupinacci, & Bush, 
2001), occupational therapy (e.g., Dubouloz, Egan, Vallerand, & von Zweck, 1999), 
psychology (e.g., Meehl, 1997), and nursing (e.g., Brady & Lewin, 2007). 
 In perhaps the most commonly used definition, Sackett, Rosenberg, Gray, Haynes, 
and Richardson (1996) describe EBP as “the conscientious, explicit and judicious use of 
current best evidence in making decisions about the care of individual patients… [by] 
integrating individual clinical expertise with the best available external clinical evidence” 
(p. 71).  In 2000, the definition was revised to include consideration of patient perspective  
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and preferences regarding their healthcare decisions (Sackett, Straus, Richardson, 
Rosenberg, & Haynes).  
 According to the American Speech-Language-Hearing Association (2008), the 
EBP procedure entails four steps: 1) framing the clinical question, 2) finding the 
evidence, 3) assessing the evidence, and 4) making the clinical decision.  At the crux of 
EBP is a three-fold clinical decision-making model in which decisions should include 
consideration of three sources: 1) evidence from systematic research, 2) the clinician’s 
clinical expertise and experiences, and 3) the values and preferences of the individual(s) 
being served (Brackenbury, Burroughs, Hewitt, 2008).  A graphic illustration of the EBP 
clinical decision-making paradigm can be found in Figure 1.  
 
 
Figure 1. Components of Clinical Decision-Making for Evidence-Based Practice 
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Benefits of EBP 
 
 In addition to the primary benefit of aiding speech-language pathologists and other 
healthcare professionals in delivering optimally effective patient care, additional 
advantages of EBP include reduction in the variation of service provisions, assisting in 
lobbying for speech-language pathology and audiology services within legislation, 
allowing clinicians to keep updated on clinical literature, and assisting to bridge the 
research-to-practice gap.  EBP also allows clinicians to become lifelong learners and 
continuously improve their clinical expertise (Peach, 2002).  
 It is also important to recognize EBP’s advantage of increased accountability, not 
only to clients and their families but to students in training and to third-party payers 
(Brackenbury et al., 2008).  According to a study by Vallino-Napoli and Reilly (2004), 
adherence to EBP principles can ease clinicians’ “constant position to support their 
diagnostic and therapeutic recommendations, justify service obtainment and continuation, 
and seek health care funding and reimbursements” (p. 107). 
 
Levels of Evidence 
 It would be imprudent and risky, however, to assume that all evidence is of equal 
quality.  According to Robey (2004), “the terms ‘levels of evidence’ or ‘strength of 
evidence’ refer to systems for classifying the evidence in a body of literature through a 
hierarchy of scientific rigor and quality” (p. 5).  Reviewers must select the most relevant 
levels-of-evidence system for the type of procedure they are assessing (e.g., diagnosis, 
prognosis, safety, efficacy, and effectiveness) (Robey, 2004).  With the field of 
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communication sciences and disorders (CSD) promoting the utilization of EBP 
principles, the American Speech-Language-Hearing Association (ASHA) has developed 
guidelines for levels of evidence in studies of treatment efficacy (2010).  These guidelines 
allow clinicians to assess the methodological quality and scientific rigor of a study which 
may influence their clinical practices. The ASHA recommended levels of evidence can be 
found in Table 1. 
 
Table 1. ASHA’s Recommended Hierarchy of Evidence (Adapted from ASHA, 2010) 
 
Level Description 
Ia.     Well-designed meta-analysis of > 1 randomized control trial 
Ib.     Well-designed randomized control study 
IIa.   Well-designed control study without randomization 
IIb.   Well-designed quasi-experimental study 
III    Well-designed non-experimental study (i.e., correlation and case 
studies) 
IV    Expert committee report, consensus conference, clinical experience 
 
 The research designs of studies vary in their ability to predict the outcomes of a 
particular clinical question.  Many researchers have developed hierarchies of evidence or 
evidence pyramids to depict the gradations in evidence.  For example, the U.S. Preventive 
Services Task Force created a five-tiered hierarchy of evidence including 1) randomized 
controlled trials (RCT), 2) nonrandomized control trials, 3) cohort or case-control studies, 
4) multiple time series, and 5) expert opinions, descriptive studies, and case reports.  
Similarly, the Oxford Centre for Evidence Based Medicine (CEBM) created an approach 
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for systematizing the process of determining evidence based on research question type.  
The Oxford CEBM’s levels of evidence can be found in Table 2. 
 
Table 2. The Oxford Centre for Evidence Based Medicine Levels of Evidence (Adapted 
from Phillips et al., 1998) 
 
Level  Description 
  1a. Systematic review (with homogeneity) of randomized-controlled 
trials (RCT) 
  1b. Individual RCT (with narrow confidence interval) 
  2a. SR (with homogeneity) of cohort studies 
  2b.  Individual cohort study (including low quality RCT) 
  2c.  “Outcomes” research; Ecological studies 
  3a.  SR (with homogeneity) of case control studies 
  3b.  Individual case-control studies 
  4 Case series and poor quality cohort and case-control studies 
  5 Expert opinion without explicit critical appraisal, or based on 
physiology, bench research, or “first principles” 
 
ASHA’s Response to EBP 
Because EBP affects all aspects of patient care, it compromises the ASHA Scope 
of Practice at all levels of clinical decision-making (ASHA, 2004).  The American 
Speech-Language-Hearing Association (ASHA) recognizes EBP as a continuous process 
with dynamic integration of clinical expertise and external evidence.  According to 
Principle I of ASHA’s Code of Ethics (2003), clinicians “shall evaluate the effectiveness 
of services rendered and of products dispensed and shall provide services or dispense 
products only when benefit can reasonably be expected” (p. 2).  With an underlying 
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theme of EBP included in each principle, the Code holds the welfare of patients 
paramount.  The Principles of the ASHA Code of Ethics can be found in Table 3. 
 
Table 3. Principles of the ASHA Code of Ethics (2003) 
 
Principle I “Individuals shall honor their responsibility to hold 
paramount the welfare of persons they serve professionally or 
participants in research and scholarly activities and shall treat 
animals involved in research in a humane manner.” 
Principle II “Individuals shall honor their responsibility to achieve and 
maintain the highest level of professional competence.” 
Principle III “Individuals shall honor their responsibility to the public by 
promoting public understanding of the professions, by 
supporting the development of services designed to fulfill the 
unmet needs of the public, and by providing accurate 
information in all communications involving any aspect of the 
professions, including dissemination of research findings and 
scholarly activities.” 
Principle IV “Individuals shall honor their responsibilities to the 
professions and their relationships with colleagues, students, 
and members of allied professions. Individuals shall uphold 
the dignity and autonomy of the professions, maintain 
harmonious interprofessional and intraprofessional 
relationships, and accept the professions' self-imposed 
standards.” 
 
ASHA also recognizes its critical role in promoting the use of EBP for speech-
language pathologists and audiologists.  In 1993, ASHA formed a Task Force on 
Treatment Outcomes and Cost Effectiveness in order to provide its members with 
outcomes data for various speech-language pathology and audiology services.  After 
reviewing national databases and data collection systems, the Task Force began 
development of a national database for the field of CSD, and in 1997 the National 
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Outcomes Measurement System (NOMS) was developed.  Designed to collect aggregated 
national outcomes data, NOMS is a data collection system used to illustrate the value of 
speech-language pathology and audiology services for individuals with communication 
and/or swallowing disorders.  
 NOMS is based on ASHA’s Functional Communication Measures (FCMs), a 
series of disorder-specific, seven-point rating scales designed to describe the change(s) in 
functional communication and/or swallowing ability over time.  FCMs are determined at 
the time of a patient’s admission and again at discharge to depict the amount of change in 
communication and/or swallowing as a result of speech and language intervention.  
Therefore, FCMs allow clinicians to demonstrate the benefit(s) of treatment to not only 
the patient but to policy makers, third party payers, and administrators.  
In 2004, Celia Hooper, vice president for professional practices in speech-
language pathology, and Ray Kent, vice president for research and technology, formed 
ASHA’s Joint Coordinating Committee on Evidence-Based Practice.  According to the 
Report of the Joint Coordinating Committee on Evidence-Based Practice (2004), the chief 
responsibility of the committee is “assessing the issues of evidence-based practice relative 
to planning needs and development opportunities” for ASHA (p. 1).   
In 2005, ASHA’s Executive Board established the Advisory Committee on 
Evidence-Based Practice as a standing committee of the Association.  The committee’s 
charge is to: 1) establish a set of terminology and definitions related to evidence-based 
practice for consistent use throughout ASHA, 2) identify and prioritize clinical questions, 
3) convene panels of independent knowledgeable reviewers to conduct evidence 
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review on clinical questions, 4) establish processes for the conduct and dissemination of 
evidence reviews, and 5) advise National Office staff on members' needs in the area of 
evidence-based practice.   
Currently, ASHA provides numerous web-based tutorials relating to different 
aspects of EBP including how to frame the clinical question, how to find the evidence, 
and how to critically make clinical decisions.  ASHA has also compiled an Evidence-
Based Practice Glossary.  Adapted from definitions from various sources including the 
Oxford Centre for Evidence-Based Medicine (CEBM), the Scottish International 
Guidelines Network (SIGN), and the University of Toronto Centre for Evidence-Based 
Medicine, ASHA’s EBP glossary provides a resource for clinicians to improve their 
understanding of EBP concepts.  
 ASHA’s National Center for Evidence-Based Practice in Communication 
Disorders (N-CEP) now provides ASHA members with an EBP Compendium, allowing 
access to practice guidelines and systematic reviews to be used as tools for clinical 
decision making.  According to ASHA, systematic reviews are “formal assessments of the 
body of scientific evidence related to a clinical question, and describe the extent to which 
various diagnostic or treatment approaches are supported by the evidence, but stop short 
of making specific recommendations for clinical practice” (www.asha.org, 2009).  ASHA 
promotes the use of systematic reviews as a time-saving resource for clinicians wishing to 
incorporate EBP into their clinical practices.  According to ASHA’s 2004 Report of the 
Joint Coordinating Committee on Evidence-Based Practice, clinical practice guidelines 
(CPG) “meet rigorous criteria and are based on a systematic review of existing scientific 
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evidence published in peer-reviewed journals” (p. 8).  Practice guidelines serve as the 
official statement of ASHA and provide guidance for incorporating evidence-based best 
practices into clinical decision making.  Furthermore, the Academy of Neurologic 
Communication Disorders and Sciences (ANCDS) provides clinicians with practice 
guidelines for the management of communication disorders in neurologically impaired 
individuals.   
 ASHA’s endorsement of EBP is not only directed toward practicing clinicians but 
also toward graduate student clinicians in training.  Revising previous certification 
standards, the 2005 Standards and Implementation Procedures for the Certificate of 
Clinical Competence (CCC) in Speech-Language Pathology went into effect for all SLP 
applicants whose applications were received beginning January 1, 2006.  As part of the 
revision, the Council for Clinical Certification (CFCC) initiated use of the Knowledge 
and Skills Acquisition (KASA) Summary Form for certification in speech-language 
pathology and audiology.  The KASA form tracks graduate students’ progress in gaining 
the knowledge and skills delineated in the Standards for Certificate of Clinical 
Competence (SCCC).  Through the use of this document, the SCCC encourages graduate 
programs to utilize the KASA form as a tracking document to demonstrate compliance 
with accreditation standards to meet ASHA certification requirements.   
 The KASA form consists of seven standards.  While use of best clinical practices 
is an underlying theme throughout the KASA form, Standard III-F explicitly addresses 
the use of EBP.  According to Standard III-F, “The applicant must demonstrate 
knowledge of the processes used in research and the integration of research principles 
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into evidence-based clinical practice” (ASHA, 2005).  To implement this standard, the 
applicant must 1) demonstrate comprehension of the principles of basic and applied 
research and research design, 2) demonstrate understanding of how to access sources of 
research information, and 3) have experience relating research to clinical practice 
(ASHA, 2005).  Graduate school program documentation in fulfillment of this standard 
may include information obtained via clinical experiences, research projects, independent 
studies, and class projects.  
 As a means of demonstrating compliance with accreditation standards to meet 
ASHA certification requirements, a majority of graduate programs nationwide are now 
utilizing the KASA form.  Therefore, since 2006, these programs now increasingly 
emphasize the role of EBP and require students to demonstrate application of research to 
clinical practice in fulfillment of KASA Standard III-F.  
 
The Research-to-Practice Gap 
 Despite the endorsement of EBP principles by ASHA, the feasibility of 
implementing such a model into everyday clinical practices remains an area of concern.  
In a 2005 survey study of 240 speech-language pathologists, Zipoli and Kennedy reported 
that although the respondents reported generally positive attitudes toward EBP and 
research, respondents reported using more traditional sources of information (i.e., clinical 
experience and opinions of colleagues) than evidence-based sources.  In accordance with 
Fey’s (2006) concerns regarding the amount of time required for EBP, the most 
frequently reported perceived barrier to EBP in Zipoli and Kennedy’s study was lack of 
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professional time.  Additional barriers dissuading clinicians from implementing EBP into 
clinical decision making include limited understanding of the components of the model 
and limited frequency with which available sources of evidence are accessed (Vallino-
Napoli & Reilly, 2004).  Furthermore, Brackenbury et al. (2008) cautions clinicians that 
research relating to a particular clinical question may be “limited, contradictory, or 
nonexistent” (p. 87). 
 An area that perhaps requires further study is the potential inverse relationship 
between clinical experience and implementation of EBP.  In a 2004 survey study of 
speech pathologists in Victoria, Australia, Vallino-Napoli and Reilly report that clinicians 
who had been practicing for more than 10 years were less likely to use research findings 
to guide clinical decision making.  Possible causes for this reduction in EBP include 
changes in training curriculum and increased reliance on clinical judgment based on 
experience.  
 The research-to-clinical practice gap must be acknowledged before suggestions 
can be made in bridging the divide.  Greenhalgh (1998) explained “There is a huge 
difference between efficacy (how well something works in the laboratory or controlled 
environment of the clinical research trial) and effectiveness (how well it works in the 
‘real world’)” (p. 3).  Similarly, Nail-Chiwetalu and Bernstein Ratner (2003) stated “it is 
difficult to achieve the goals of [EBP] if one cannot obtain and interpret the evidence 
appropriately” (p. 166-167). 
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Overcoming the Research-to-Practice Gap 
 To mitigate the effects of the research-to-practice gap and to promote the union of 
research and clinical services, various strategies and guidelines are available on how to 
effectively utilize EBP (e.g., Gillam & Gillam, 2006; Johnson, 2006).  In 2000, Law 
proposed an eight-step scheme for transferring research into clinical practice.  A summary 
of Law’s eight-step scheme can be found in Table 4.  
 
Table 4. Eight-Step Scheme for Transferring Research into Clinical Practice (Adapted 
from Law, 2000) 
 
Step 1 Clearly identify the clinical problem. 
Step 2 Gather information from research studies about this problem. 
Step 3 Ensure that you have adequate knowledge to read and critically analyze 
the research studies. 
Step 4 Decide if a research article or review is relevant to your clinical problem 
in which you are interested. 
Step 5 Summarize the information so that it can be easily used in your practice. 
Step 6 Define the expected outcomes for the client and their families. 
Step 7 Provide education and training to implement the suggested change in 
practice. 
Step 8 Evaluate the practice, change, and modify (if necessary). 
 
 In a 2004 article, Robey presented an adaptation to a five-phase model of clinical-
outcome research, which had previously been used by the broader research community, as 
a means of structuring the many forms of research in speech-language pathology and 
audiology.  This model can be utilized as a guide to EBP by assisting clinicians in 
identifying new treatment protocols and appropriately interpreting the available research. 
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 A summary of each phase, including its purpose, research tasks, and evidence level, can 
be found in Table 5. 
 
Table 5. Summary of Robey’s Five-Phase Model for Evaluating Research (Adapted from 
Robey, 2004) 
 
Phase Purpose Method(s) Type(s) of Evidence 
I Selecting 
therapeutic 
effect, 
identifying if 
effect is 
present, and 
estimating the 
effect’s 
magnitude 
1. Make point and interval 
estimates of effect size 
2. Approximate population 
definitions 
3. Approximate treatment 
protocol 
4. Estimate appropriate dose 
5. Specify therapeutic effect 
6.  Generate/refine hypotheses 
Case studies, 
discovery-oriented 
single-subject studies, 
small-group pre-post 
studies, & 
retrospective studies 
II Exploring the 
dimension of 
therapeutic 
effect and 
making 
preparation for 
conducting 
clinical trial 
1. Determine indications of 
efficacy 
2. Refine target population 
3. Assess therapeutic effect’s 
range of utility 
4. Refine treatment protocol and 
develop administration manual 
5. Determine discharge criteria 
6. Determine optimal dosage 
7. Assess duration of effect 
8. Identify measurement 
instruments 
9. Finalize operational definitions 
Case studies, 
discovery-oriented 
single-subject studies 
(as logical extensions 
of Phase I), single-
subject studies, 
small-group within-
effect studies, case-
control studies, & 
small-group cohort-
control studies 
III Conduct a 
clinical trial to 
test efficacy 
1. Compare obtained point and 
interval estimates of effect size 
with estimates produced by 
other experiments on the same 
or similar problem 
Parallel-group 
designs & single-
subject design studies 
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Table 5 (Continued). Summary of Robey’s Five-Phase Model for Evaluating Clinical-
Outcome Research (Robey, 2004) 
 
Phase Purpose Method(s) Type(s) of Evidence 
IV Assess the degree 
to which 
therapeutic effect 
is realized in day 
to day clinical 
practice 
1. Test effectiveness in target 
population 
2. Test effectiveness in specific 
sub-populations 
3. Test effectiveness under 
variations of service-delivery 
models 
4. Test effectiveness variants of 
treatment protocol 
5. Conduct meta-analyses of 
efficacy studies 
Pre- versus post-
studies, parallel-
group studies, & 
hypothesis-driven 
single-subject studies 
V Determine who 
benefits from the 
treatment and at 
what cost 
1. Assess costs and values in 
fiscal and societal terms via 
cost-benefit analysis 
Cost-effectiveness 
studies 
 
Furthermore, Robey (2004) presented an adaptation to the Consolidated Standards 
of Reporting Trials (CONSORT) document as a framework for evaluating the scientific 
value of a report.  Using the CONSORT framework, evaluating quality is determined 
through evaluation of threats to internal, external, statistical conclusion, and construct 
validities.  Therefore, both Robey’s five-phase model for evaluating clinical-outcome 
research and the CONSORT document can be used by clinicians to organize research and 
optimize use of EBP interventions.   
Robey (2004) also claims that the importance of meta-analyses should not be 
overlooked during the process of formulating EBP practice guidelines.  The author states 
“Because a meta-analysis of all studies testing the efficacy of a certain treatment protocol 
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is a synthesis of all relevant findings on the question, the results figure prominently in the 
formulation of evidence-based practice guidelines” (p. 406).  The Cochrane 
Collaboration, which consists of 52 review groups, is considered the gold standard of 
systematic reviews.  Originally created to inform healthcare decision, the Cochrane 
Collaboration is now used to inform treatment and intervention decisions in disciplines 
other than health, including speech-language pathology.  Cochrane’s systematic reviews 
synthesize data to provide an overall measure of the effectiveness of a particular 
intervention and provide a review of the methodologies that are most appropriate.  The 
Cochrane Handbook, which provides guidance to authors for the preparation of a 
Cochrane Intervention review, can be accessed at http://www.cochrane-handbook.org/.  
 
Limitations of EBP in !eurological Communication Disorders 
 With the EBP model in hand, speech-language pathologists can methodically 
scrutinize the literature, evaluate the quality of the research, and use their clinical 
expertise to decide on the appropriateness of a particular treatment approach for a client.  
However, the important question remains, how well do clinicians’ perceptions of which 
treatment approaches are evidence based match the treatment outcomes in EBP literature? 
 In this regard, Borden, Harris, and Raphael (2002) stated “our perceptions often match 
our expectations rather than what was actually said and heard” (p. 151).  We have already 
seen that over time speech-language pathologists tend to rely more on personal 
experiences and clinical judgment than current research (Zipoli & Kennedy, 2005).  
Referring to what Silliman (1999) called the “seeing is knowing” phenomenon, clinicians 
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may be more affected by observable outcomes than by published reports.  Moreover, 
clinicians may be persuaded by commercial propaganda or advertisements and coaxed 
into thinking these marketed approaches are indeed evidence based.  
 Rehabilitation of neurological communication disorders is vulnerable to the use of 
therapeutic practices without evidentiary support.  Before any attempts to bridge the 
research-to-clinical practice gap can be made, we must first have a clear understanding of 
the perceptions clinicians are holding of what is and is not evidence based.  There have 
been several survey studies designed to identify potential barriers to EBP (e.g., Metcalf et 
al., 2001) and attitudes toward EBP (e.g., Zipoli & Kennedy, 2005; Vallino-Napoli & 
Reilly, 2004).  However, few studies have been designed to probe what treatment 
approaches to neurogenic communication disorders clinicians are currently implementing 
and the rationales behind their implementation.  Furthermore, a review of the literature 
failed to identify a survey designed to probe the correlation between what clinicians 
perceive to be evidence based and what truly is evidence based as measured by support in 
the literature.  Therefore, the need remains for a survey study probing perceptions of 
evidence as they relate to EBP in clinical decision-making.  If a disconnect is found 
concerning the accuracy of perceptions of evidence and the implementation of EBP, 
contributing factors may be identified and addressed.   
 The primary objective of the current study is to investigate the treatment 
approaches clinicians are currently implementing to treat aphasia, and where and how 
information is obtained related to each approach.  The secondary objective of this study is 
to compare the perceived level of evidence for each treatment approach versus the actual 
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evidence available in current literature and practice guidelines.  Also studied is the 
amount of time required for a clinician to first become exposed to an individual treatment 
approach and to implement the approach in their regular clinical practices. The overall 
goal, therefore, is to examine potential trends within the field of speech-language 
pathology relating to role of EBP in the clinical decision-making of aphasia therapy and 
the quality of evidentiary support for these decisions.  
 
Research Questions 
 The current study will address the following research questions:  
1. Do current clinicians of neurogenic communication disorders implement 
evidence-based practices? 
2. Where are clinicians obtaining information regarding the practices they are 
implementing? 
3. Are the perceptions of what clinicians believe to be evidence-based in accordance 
with available practice guidelines? 
4. How much time typically passes between when a clinician is first exposed to and 
when he/she first implements different treatment approaches? 
5. What factors contribute to the lag in time between exposure to and 
implementation of treatment approaches? 
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CHAPTER TWO: 
METHODS 
Instrument  
 The survey, which appears in Appendix A, consists of six sections and was 
designed to obtain information about the ways that speech-language pathologists obtain 
information and the perceived level of evidence for various treatment approaches for 
aphasia.  The survey was designed in accordance with the five stages in the development 
and completion of a survey as described by Czaja and Blair (2005).  These stages include 
1) preliminary planning and survey design, 2) pre-testing of the questions, 3) final survey 
planning and design, 4) data collection, and 5) data coding and analysis.    
 Section I of the survey included of 11 questions and probes background 
information, including items addressing primary work setting, years of experience, 
highest degree earned, percentage of caseload consisting of patients with aphasia, and 
specialty credentials earned by participating SLPs. 
 Section II of the survey was designed to obtain information regarding the 
treatment approaches and/or devices clinicians are currently using in the treatment of 
aphasia.  This section consisted of a list of 18 aphasia treatment approaches, and 
respondents were asked to select all of the treatments they have used and/or 
recommended within the last year of providing services to patients with aphasia.  Space 
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was provided for respondents to provide information regarding any additional treatment 
approaches that are not included in the survey list.  A list of the 18 treatment approaches 
included in the survey and a brief description of each can be found in Appendix B.  
 Section III of the survey was designed to obtain information regarding the 
perceived levels of evidence for various aphasia treatment approaches.  Using the same 
list of treatment approaches as in Section I, this section asked respondents to rate their 
perceived levels of evidence for these treatment approaches using a 4-point Likert scale:  
1) no evidence, 2) minimal evidence, 3) moderate evidence, or 4) strong evidence. 
 Section IV of the survey was designed to obtain information regarding clinicians’ 
primary means of obtaining information for treatment approaches they have used and/or 
recommended within the last year.  Using the same list of treatment approaches as in 
Section I and a numeric value answer key, respondents reported that they 1) learned about 
it in graduate school, 2) learned about it at a conference or workshop, 3) learned about it 
through an advertisement (e.g., ASHA’s Online Buyer’s Guide, magazine, catalog), 4) 
learned about it in a professional magazine (e.g., Advance, Stroke Connection Magazine, 
The ASHA Leader), 5) learned about it in a professional journal (e.g., American Journal 
of Speech-Language Pathology, Aphasiology, Journal of Speech, Language, and Hearing 
Research), 6) a colleague recommended it, or 7) other.  
 Section V of the survey was designed to obtain information regarding how much 
exposure to a particular treatment approach was required by a clinician before they began 
implementing the approach in their regular clinical practices.  Using the same list of 
treatment approaches as in Section I and a numeric value answer key, respondents were 
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asked to report the approximate amount of time that passed between when they were first 
exposed to and when they first implemented each approach.  Respondents reported that 
the amount of time was 1) 0-3 months, 2) 4-6 months, 3) 6-9 months, 4) 9-12 months, or 
5) >12 months.  A follow-up question then probed to identify which variables contributed 
to the time lag between exposure to and implementation of treatment approaches.  
Respondents reported that the time lag was due to 1) not having the appropriate 
client/caseload for the treatment, 2) wanting to learn more about the treatment’s 
procedures, 3) limited time for gathering materials for the treatment, 4) materials for the 
treatment could not be purchased, 5) desire to review the evidence base for the treatment, 
6) desire to ask colleagues’ opinions of the treatment, and/or 7) other.  
 Section VI of the survey, which consists of two open-ended questions, was 
designed to encourage respondents to discuss factors that may facilitate the use of EBP in 
their treatment of patients with aphasia.  This section also allowed respondents to report 
and describe situations which prompted them to seek and implement alternative treatment 
approaches for their patient(s) with aphasia. 
 This survey study has a causal comparative research design.  The independent 
variables are the survey questions (i.e., demographics questions and questions related to 
individual treatment approaches).  The dependent variables are the responses to 
questions, both qualitative (those responses to open-ended questions) and quantitative 
(those numerical responses associated with closed-ended or mutually exclusive 
questions).  The survey responses were all nominal or open-ended data and were analyzed 
descriptively. 
21 
 
Item Development 
  A systematic approach was used in the selection of treatments to be presented in 
the survey.  First, aphasia treatment approaches with a reasonable evidence base were 
selected for inclusion in the survey.  For the purposes of this study, this level of evidence 
was demonstrated by a systematic review of studies that 1) are considered to be Class II 
level of evidence or higher and 2) include an adequate number of participants to infer 
generalizability.  In order to use a practical guideline, published systematic reviews from 
the Academy of Neurologic Communication Disorders and Sciences (ANCDS) Evidence 
Based Practice Guidelines for the Management of Communication Disorders in 
Neurologically Impaired Individuals were reviewed.  A summary of these systematic 
reviews, including the levels of evidence for the studies reviewed and overall evidentiary 
support for the treatment approaches, is presented in Table 6.  
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Table 6. Summary of the Levels of Evidence in Systematic Reviews of Various 
Treatment Approaches for Aphasia Accessed by the ANCDS  
  
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Bayles et al. 
(2006) 
Simulated 
presence 
therapy 
(SimPres) in 
dementia of the 
Alzheimer type 
(DAT) 
Yes; 
“The feasibility, 
pilot, and 
efficacy studies 
support the 
positive effects 
of SimPres on 
agitated and 
withdrawn 
behaviors 
produced by 
individuals with 
moderate to 
severe DAT” (p. 
xix) 
3 studies 
 
Study 1: Class II 
(Intermediate) 
Study 2: Class II 
(Intermediate) 
Study 3: Class II 
(Intermediate) 
Cherney et al. 
(2008) 
Constraint-
induced 
language 
therapy (CILT) 
in aphasia 
Yes; 
“In chronic 
aphasia, studies 
provided modest 
evidence for 
more intensive 
treatment and the 
positive effects 
of CILT” (P. 
1282) 
5 studies 
 
Study 1: Class II 
(Intermediate) 
Study 2: Class III 
(Weakest) 
Study 3: Class II 
(Intermediate) 
Study 4: Class I 
(Highest) 
Study 5: Class III 
(Weakest) 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS  
  
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Hopper et al. 
(2005) 
Spaced-
retrieval (SR) 
training in 
dementia 
Yes; 
Results were 
“generally 
positive in that 
the large 
majority of the 
participants 
learned some or 
all of the target 
information and 
behaviors being 
taught” (p. xxxi); 
“The results 
were 
overwhelmingly 
positive” (p. 
xxxii) 
15 studies Study 1: Class III 
(Weakest) 
Study 2: Class III 
(Weakest) 
Study 3: Class III 
(Weakest) 
Study 4: Class III 
(Weakest) 
Study 5: Class III 
(Weakest) 
Study 6: Class III 
(Weakest) 
Study 7: Class III 
(Weakest) 
Study 8: Class III 
(Weakest) 
Study 9: Class III 
(Weakest) 
Study 10: Class II 
(Intermediate) 
Study 11: Class II 
(Intermediate) 
Study 12: Class II 
(Intermediate) 
Study 13: Class II 
(Intermediate) 
Study 14: Class II 
(Intermediate) 
Study 15: Class II 
(Intermediate) 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS   
 
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Kennedy et al. 
(2005) 
Self-regulation 
in patients with 
TBI 
Yes; 
“Several studies 
have 
documented the 
efficacy and 
effectiveness of 
intervention 
aimed at 
improving 
problem solving 
through 
sequences of 
steps, including 
self-monitoring” 
(p. 252) 
10 studies Not specified; 
Authors currently 
critiquing 
evidence 
Kennedy 
(2008) 
Executive 
functions (e.g., 
problem 
solving, 
planning, and 
organizing) in 
TBI 
Yes; 
“All studies 
reported positive 
immediate 
treatment 
outcomes based 
on our 
qualitative and 
quantitative 
analyses” (p. 35) 
15 studies Class I: 5 studies 
Class II: 3 studies 
Class III: 7 
studies 
 
 
 
 
25 
 
Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS 
   
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Kim et al. 
(2006) 
Group 
reminiscence 
therapy in 
dementia 
Yes; 
“Provide 
preliminary 
evidence for the 
positive effects 
that group RT 
can have on 
communication 
and cognition of 
individuals with 
dementia” (p. 
xxxi) 
6 studies Study 1: Class II 
(Intermediate) 
Study 2: Class II 
(Intermediate) 
Study 3: Class II 
(Intermediate) 
Study 4: Class II 
(Intermediate) 
Study 5: Class II 
(Intermediate) 
Study 6: Class II 
(Intermediate) 
Mahendra et al. 
(2005) 
Computer-
assisted 
cognitive 
interventions 
(CACIs) in 
dementia 
Inconclusive; 
“All three 
studies reviewed 
were classified 
as providing 
Class II evidence 
in support of the 
use of CACIs 
with dementia 
patients. 
However, 
considerable 
research is 
needed before 
making stronger 
conclusions” (p. 
xli) 
3 studies Study 1: Class II 
(Intermediate) 
Study 2: Class II 
(Intermediate) 
Study 3: Class II 
(Intermediate) 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS   
 
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Mahendra et al. 
(2006) 
Montessori-
based 
intervention in 
dementia 
inconclusive; 
“Montessori 
activities were 
more beneficial 
than regular or 
routine activities 
in improving 
performance on 
cognitive 
measures, 
engagement 
levels, affective 
states, and social 
interaction. 
However, more 
information is 
necessary 
regarding the 
nature and 
implementation 
of regular 
activities and 
how these differ 
from Montessori 
activities before 
strong 
conclusions can 
be drawn” (p. 
xxii) 
5 studies Study 1: Class II 
(Intermediate) 
Study 2: Class II 
(Intermediate) 
Study 3: Class III 
(Weakest) 
Study 4: Class III 
(Weakest) 
Study 5: Class III 
(Weakest) 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS   
 
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
 
Sohlberg et al. 
(2003) 
Direct 
attention 
training in TBI 
No; 
“Our review 
process 
highlights the  
need for research 
that better 
described the 
specific elements 
of attention 
training that are 
most effective in 
particular 
contexts and the 
outcomes that 
result from such 
training” (p. 
xxxvi) 
9 studies Study 1: Class I 
(Highest) 
Study 2: Class II 
(Intermediate) 
Study 3: Class I 
(Highest) 
Study 4: Class I 
(Highest) 
Study 5: Class II 
(Intermediate) 
Study 6: Class II 
(Intermediate) 
Study 7: Class II 
(Intermediate) 
Study 8: Class II 
(Intermediate) 
Study 9: Class II 
(Intermediate) 
Sohlberg et al. 
(2007) 
Use of external 
aids for the 
management of 
memory 
disorders in 
traumatic brain 
injury 
Yes;  
“The studies are 
universally 
supportive of the 
general practice 
of using external 
aids to 
compensate for 
memory 
impairments” (p. 
xxii) 
21 studies Class I:   1 study 
Class II:  10 
studies 
Class III: 10 
studies 
Class IV: 0 
studies 
Class V:  0 
studies 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS 
   
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Ylvisaker et al. 
(2007) 
Behavioural 
intervention 
for children 
and adults with 
behaviour 
disorders after 
TBI 
Yes; 
“Both traditional 
contingency 
management 
procedures and 
positive behavior 
support 
procedures can 
be said to be 
evidence-based 
treatment 
options”  
(p. 769)  
65 studies Class I:   2 studies 
Class II:  1 study 
Class III: 36 
studies 
Class IV: 26 
studies 
Class V:  0 
studies 
Zientz et al. 
(2007) 
Caregiver- 
administered 
active 
cognitive 
stimulation in 
Alzheimer’s 
disease (AD)  
Yes; 
“The three 
studies reviewed 
provide Class II 
evidence to 
support the 
training of 
family caregivers 
to administer 
active cognitive 
stimulation to 
individuals with 
AD” (p. xxxii) 
3 studies Study 1: Class II 
(Intermediate) 
Study 2: Class II 
(Intermediate) 
Study 3: Class II 
(Intermediate) 
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Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ANCDS   
 
Reference Type of 
Treatment 
Does the 
Review Support 
Evidence for 
This 
Treatment? 
# of 
Studies 
Reviewed 
to Support 
EBP  
Level of 
Evidence 
Zientz et al. 
(2007) 
Caregiver-
administered 
communication 
strategies in 
Alzheimer’s 
disease (AD) 
Yes;  
The studies show 
“evidence for 
education and 
communication 
training of 
family and 
professional 
caregivers of 
individuals with 
AD and other 
types of 
dementia” (p. lx) 
7 studies Study 1: Class I 
(Highest) 
Study 2: Class II 
(Intermediate) 
Study 3: Class II 
(Intermediate) 
Study 4: Class II 
(Intermediate) 
Study 5: Class II 
(Intermediate) 
Study 6: Class II 
(Intermediate) 
Study 7: Class III 
(Weakest) 
 
  The American Speech-Language-Hearing Association (ASHA) Compendium of 
EBP Guidelines and Systematic Reviews was also accessed in order to review evidence-
based aphasia treatment approaches.  Additional factors affecting clinical decision 
making were also reviewed including intensity of treatment, potential effects of formal 
versus informal aphasia treatments, and caregiver burden of various treatments.  A 
summary of these systematic reviews, including the levels of evidence for the studies 
reviewed and overall evidentiary support for the treatment approaches, is presented in 
Table 7. 
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Table 7. Summary of the Levels of Evidence in Systematic Reviews of Various 
Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Bhogal et al. 
(2003) 
To determine 
the 
relationship 
between 
treatment 
intensity and 
recovery 
Yes;  
Intense therapy 
over a short 
amount of time 
can improve 
outcomes of 
speech and 
language 
therapy for 
stroke patients 
with aphasia; 
“Studies that 
demonstrated a 
significant 
treatment effect 
provided 8.8 
hours of therapy 
per week for 
11.2 weeks 
versus the 
negative studies 
that only 
provided ~2 
hours per week 
for 22.9 weeks” 
(abstract, p. 1) 
10 studies Study 1: Class I 
(Highest) 
Study 2: Class I 
(Highest) 
Study 3: Class I 
(Highest) 
Study 4: Class I 
(Highest) 
Study 5: Class I 
(Highest) 
Study 6: Class I 
(Highest) 
Study 7: Class I 
(Highest) 
Study 8: Class I 
(Highest) 
Study 9: Class I 
(Highest) 
Study 10: Class I 
(Highest) 
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Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Bhogal et al. 
(2003) 
To develop 
the “more is 
better” idea 
within the 
framework of 
aphasia 
therapy and 
examines 
aspects that 
may be 
combined to 
facilitate 
recovery 
No;  
“four studies 
demonstrated a 
positive impact 
of aphasia 
therapy and 
four studies 
demonstrated 
no significant 
impact of 
aphasia therapy 
on recovery” (p. 
67) 
8 studies Study 1: Class I 
(Highest) 
Study 2: Class I 
(Highest) 
Study 3: Class I 
(Highest) 
Study 4: Class I 
(Highest) 
Study 5: Class I 
(Highest) 
Study 6: Class I 
(Highest) 
Study 7: Class I 
(Highest) 
Study 8: Class I 
(Highest) 
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Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Greener et al. 
(1999) 
To determine 
1) whether 
formal speech 
and language 
therapy is 
more effective 
than no 
therapy in 
improving 
expressive 
and receptive 
language,  
2) whether 
formal 
therapy is 
more effective 
than non-
professional 
support,  
3) whether 
non-
professional 
support is 
more effective 
than no 
support,  
4) whether 
formal 
therapy is 
more effective 
than another 
type of 
support 
Inconclusive; 
“speech and 
language 
therapy 
treatment for 
people with 
aphasia after a 
stroke has not 
been shown 
either to be 
clearly effective 
or clearly 
ineffective 
within a 
randomized 
controlled trial. 
Decisions about 
management of 
patients must 
therefore be 
based on other 
forms of 
evidence. 
Further research 
is required to 
find out if 
effectiveness of 
speech and 
language 
therapy for 
aphasic patients 
is effective” 
(abstract, p. 1) 
12 studies Study 1: Class I 
(Highest) 
Study 2: Class I 
(Highest) 
Study 3: Class I 
(Highest) 
Study 4: Class I 
(Highest) 
Study 5: Class I 
(Highest) 
Study 6: Class I 
(Highest) 
Study 7: Class I 
(Highest) 
Study 8: Class I 
(Highest) 
Study 9: Class I 
(Highest) 
Study 10: Class I 
(Highest) 
Study 11: Class I 
(Highest) 
Study 12: Class I 
(Highest) 
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Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Greener et al. 
(2001) 
The effect of 
drugs on 
language 
abilities when 
given to 
people with 
aphasia 
following a 
stroke 
Inconclusive; 
“We could not 
determine if 
drug treatment 
is more 
effective than 
speech and 
language 
therapy. We 
could not 
determine 
whether one 
drug is more 
effective than 
another” (p. 1); 
“Further 
research is 
needed to 
explore the 
effects of drugs 
for aphasia, in 
particular 
piracetam”  
(p. 1) 
10 studies Study 1: Class I 
(Highest) 
Study 2: Class I 
(Highest) 
Study 3: Class I 
(Highest) 
Study 4: Class I 
(Highest) 
Study 5: Class I 
(Highest) 
Study 6: Class I 
(Highest) 
Study 7: Class I 
(Highest) 
Study 8: Class I 
(Highest) 
Study 9: Class I 
(Highest) 
Study 10: Class I 
(Highest) 
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Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Rombough et al. 
(2006) 
Examines the 
literature on 
the 
burden/strain 
experienced 
by caregivers 
of stroke 
patients and 
examines the 
relationship 
between 
aphasia and 
this 
burden/strain 
No;  
The review 
suggests the 
lack of research 
regarding the 
relationship 
between 
aphasia and 
caregiver 
burden/strain 
and key 
initiatives are 
needed 
including the 
development of 
an instrument 
with  
psychometric 
properties 
appropriate for 
assessing this 
relationship  
(p. 1) 
14 studies Quantitative 
articles: 12 
studies 
Mixed design 
study: 1 study 
Qualitative 
study: 1 study 
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Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of 
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium 
 
 Reference Type of 
Treatment/ 
Purpose 
Does the 
Review 
Support 
Evidence for 
This 
Treatment? 
# of Studies 
to 
Reviewed 
to Support 
EBP 
Level of 
Evidence 
Rombough et al. 
(2007) 
Review to 
determine the 
appropriate 
design studies 
and 
instruments 
used to assess 
quality of life 
(QOL) in 
caregivers of 
stroke 
survivors 
N/A;  
The majority of 
caregivers 
reviewed were 
women and 
spouses with 
average ages 
between 50 and 
60 years; Small 
sample sizes of 
included studies 
limit 
generalizability 
(p. 77) 
9 studies Study 1: Class III 
(Weakest) 
Study 2: Class III 
(Weakest) 
Study 3: Class I 
(Highest) 
Study 4: Class III 
(Weakest) 
Study 5: Class I 
(Highest) 
Study 6: Class III 
(Weakest) 
Study 7: Class II 
(Intermediate) 
Study 8: Class I 
(Highest) 
Study 9: Class III 
(Weakest) 
 
  The Practice Guidelines of the ANCDS and the ASHA EBP Compendium were 
chosen to aid in the selection of treatment approaches for the survey because both are 
readily available sources of evidence-based information for clinicians.  Both sources are 
easily accessible as they do not require payments or university access to view 
publications, and they do not require membership to any organizations beyond ASHA.  
Therefore, published systematic reviews and practice guidelines may be accessed at these 
sources by any clinician who possesses ASHA certification and internet access.  
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  Based on the review of practice guidelines and systematic reviews presented in the 
Practice Guidelines of the ANCDS and ASHA EBP Compendium, a decision was made 
to include treatment approaches in the survey that have a reasonable level of evidence.  
As previously stated, this level of evidence was demonstrated by a systematic review of 
studies that 1) are considered to be Class II level of evidence or higher and 2) include an 
adequate number of participants to infer generalizability.  Furthermore, the studies 
reviewed in each systematic review must be in accordance to support a basic level of 
efficacy for the treatment.   
  Also included in the survey are aphasia treatment approaches that may or may not 
be evidence based but are advertised and may be familiar to clinicians.  In order to 
determine the types of treatments, software, alternative communication devices, and/or 
instrumentation to which clinicians treating aphasia may regularly be exposed, several 
professional magazines were reviewed for commercial advertisements including 
ADVA!CE for Speech-Language Pathologists & Audiologists, Stroke Connection 
Magazine, and The ASHA Leader.  Additional advertisements were searched in ASHA’s 
Online Buyer’s Guide.  A basic Google search for the keywords “aphasia treatment 
products” and “aphasia treatment approaches” was also conducted in order to determine 
which treatments clinicians may access via a commonly-used search engine.   
  Treatments selected for inclusion in the survey, therefore, met at least one of two 
possible inclusion criteria:  1) the treatment met the pre-determined basic level of 
evidence and/or 2) the treatment may or may not be supported by evidence but is highly 
advertised and easily accessed by clinicians.  Therefore, treatment approaches included in 
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the survey are either drawn from a list of evidence-based treatments or drawn from a list 
of advertised treatments, with or without an evidence base.   
  After reviewing ADVA!CE for Speech-Language Pathologists & Audiologists, 
Stroke Connection Magazine, The ASHA Leader, and ASHA’s Online Buyer’s Guide, the 
18 treatment approaches included in the survey were categorized based on 
presence/absence of advertising and evidence base.  Three treatment approaches were 
categorized as “evidence based and advertised.”  Specifically, these treatments included 
1) augmentative and alternative communication (AAC), 2) picture naming therapy, and 
stimulation approach (e.g., workbooks). 
  Eleven treatment approaches were categorized as “evidence based and not 
advertised.”  These treatments included 1) communication partner training (CPT), 2) 
constraint-induced aphasia therapy (CIAT), 3) functional communication therapy (FCT), 
4) intensive aphasia therapy, 5) melodic intonation therapy (MIT), 6) promoting aphasics’ 
communicative effectiveness (PACE), 7) response elaboration training (RET), 8) 
semantic feature analysis (SFA), 9) sentence production program for aphasia, 10) spaced-
retrieval training, and 11) treatment for underlying forms (TUF).   
  Four treatment approaches were categorized as “no/limited evidence base and 
advertised.”  These treatments included use of 1) computer treatments, 2) Interactive 
Metronome® (IM), 3) Sentactics®, and 4) SentenceShaper®.  No treatment approach 
was categorized as having “no/limited evidence base and not advertised.”  A summary of 
the categorization of the treatment approaches included in this study is presented in  
Table 8. 
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Table 8. Treatment Approach Categorization Based on Advertising and Evidence 
 
 
Content Validity 
  Survey pre-testing was conducted in consideration of Czaja and Blair (2005) who 
suggested the “benefit of testing seems to come from simply exposing the questionnaire 
 Evidence Base 
+ 
.o/Limited Evidence Base 
-- 
 
 
 
 
Advertised 
 
  + 
1. Augmentative and Alternative 
Communication (AAC)  
(e.g., DynaVox®; Say-it! SAM 
Communicator®) 
2. Picture Naming Therapy  
(e.g., picture naming kits) 
3. Stimulation Approach  
(e.g., Workbooks) 
1. Computer Treatments  
(e.g., Parrot Software®; 
Bungalow Software®; 
Lingraphica®) 
2. Interactive Metronome ® 
3. Sentactics® 
4. SentenceShaper® 
 
 
 
 
 
 
 
        .ot 
  
Advertised 
 
        -- 
1. Communication Partner Training 
(CPT) (e.g., Supported 
Conversation) 
2. Constraint-Induced Aphasia 
Therapy (CIAT) 
3. Functional Communication 
Therapy (FCT) 
4. Intensive Aphasia Therapy 
5. Melodic Intonation Therapy 
(MIT) 
6. Promoting Aphasics’ 
Communicative Effectiveness 
(PACE) 
7. Response Elaboration Training 
(RET) 
8. Semantic Feature Analysis (SFA) 
9. Sentence Production Program for 
Aphasia (formerly HELPSS) 
10. Spaced-Retrieval Training (SRT) 
11. Treatment for Underlying Forms 
(TUF) 
No treatment approaches 
identified 
39 
 
to people not involved in its construction,” (p. 6).  Following several initial drafts and 
revisions of the survey, a precursor to the survey used in this study was piloted to a panel 
of three expert reviewers to enhance content validity and improve the utility of the survey. 
 Two of these reviewers were doctorate-level university faculty members with current 
state licensure and the CCC-SLP.  The third reviewer was a doctorate-level student within 
the Department of Communication Sciences and Disorders at the university where the 
survey was developed.   
  The reviewers provided written and verbal feedback regarding appropriateness of 
survey items, representativeness of items with regard to clinical practice patterns, and 
suggestions for improving the visual appeal and layout of the instrument.  Specifically, 
the answer keys for questions 13-15 were moved to the top of the page in order to 
improve utility of these questions.  The amount of space provided for participants to write 
responses to open-ended questions and information related to “other” responses was also 
increased.  The final survey, which appears in Appendix A, reflects the suggestions 
provided by these reviewers.  
 
Participants 
  Survey respondents met the following criteria: 1) certified speech-language 
pathologist and 2) regularly provide services to patients with aphasia.  Respondents were 
contacted via 1) the e-mail listserv of the American Speech-Language-Hearing 
Association Special Interest Division 2, 2) the state representatives’ e-mail listserv of the 
National Aphasia Association (NAA) database, and 3) select monthly meetings of the 
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Tampa Bay Medical Speech Pathology Association (MESPA).  Recruited participants 
were working adults ranging from 20 to 60+ years of age.  Gender and ethnicity of the 
respondents reflect demographics of the profession in this specialty.  Overall, it is 
estimated that 4,500 potential respondents were contacted.  
Recruitment efforts attempted to draw a sample of participants that presumably is 
representative of the total population of SLPs providing services to patients with aphasia. 
 According to Fitz-Gibbon & Morris (1987), a sample size of 30 is considered adequate 
for statistical analysis purposes regardless of the size of the group being represented.  
Albeit, the larger the sample the better for ensuring that responses adequately represent 
the opinions and attitudes of the larger population.  According to ASHA, there are 
approximately 110,000 ASHA-certified SLPs of which 35% (i.e., 38,500) are employed 
in healthcare facilities.  According to Krejcie & Morgan’s (1970) table for determining 
sample size from a given population, which is based on a formula published by the 
research division of the Nation Education Association (NEA), the recommended sample 
size for the current study is approximately 379.    
 
Procedure 
  The surveys were electronically mailed (Appendix C) and/or provided in a hard 
copy format to potential respondents.  All questionnaires were accompanied by a cover 
letter (Appendix D) to briefly explain the purpose of the study, provide a statement of 
informed consent, and explain that participant identities would remain anonymous and 
responses would be confidential.  Participants consisted of those speech-language 
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pathologists who return a completed survey.  The identities of all participants were kept 
anonymous and all responses remain confidential via deletion of clinician names from 
surveys and separation of respondent correspondence from surveys.    
  The de-identified survey data was analyzed and compared to the current literature 
base and practice guidelines for the selected treatment approaches.  During analysis, 
consideration was given to how clinicians are obtaining information on particular 
treatment approaches, whether clinician perceptions on evidence-based approaches are 
consistent with evidentiary support, and what factors contribute to the time lag between 
exposure to and implementation of treatment approaches.  Raw data is reported in 
Appendix E. 
 
Assumptions 
Based on the research questions presented and the survey design implemented, 
several assumptions must be made.  First, because a survey study relies on a self-report 
method of data collection, respondents must be assumed to be accurate reporters of their 
own behaviors and perceptions.  Second, because the current study is based on a sample 
of clinicians providing services to patients with neurogenic communication disorders, it 
must be assumed that the sample effect(s) can be generalized to the greater population of 
clinicians.  Finally, because this research design is descriptive, not explanatory, results 
cannot offer insight into potential cause-effect relationships.  Therefore, results can only 
be assumed to be useful in describing characteristics of rehabilitation professionals as 
they relate to EBP. 
42 
 
 
 
 
CHAPTER THREE: 
RESULTS 
 The role of evidence-based practice (EBP) in the clinical decision-making of 
aphasia treatment was examined in the current study.  Launching both Web-based and 
hard copy versions of an 18-question survey, questions probed clinician perceptions of 
the evidence level, primary sources of information, and timeframe of implementation 
related to various traditional treatment approaches for aphasia.   
 Of the estimated 4,500 potential respondents contacted via the American Speech-
Language-Hearing Association (ASHA) Special Interest Division 2 listserve, the state 
representatives’ e-mail listserv of the National Aphasia Association (NAA) database, and 
monthly meetings of the Tampa Bay Medical Speech Pathology Association (MESPA) 
during the recruitment period, 117 (2.6%) responses were obtained.  In an attempt to 
ensure the highest quality data possible, each of the 117 completed surveys was reviewed, 
and erroneous responses were deleted by the principle investigator with primary 
responsibility for the survey.  Of the 117 completed surveys, 13 surveys were excluded 
from data analysis because the respondents either 1) reportedly do not currently provide 
services to patients with aphasia (N = 8) or 2) terminated survey participation after the 
first question (N = 5).  Therefore, a total of 104 responses were eligible for data analysis.   
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 Demographics 
 Section I consisted of 11 questions probing demographic characteristics of survey 
respondents.  Respondents were all speech-language pathologists (SLP) who currently 
provide services to patients with aphasia.  Although not required in all states, 93.3% (N = 
97) of respondents reported having current state licensure in SLP.  Of the 104 
respondents, 92.3% (N = 96) were female and 7.7% (N = 8) were male.   
 The majority of respondents were between 40 and 60 years of age (N = 71, 
68.3%).  Specifically, the age range of respondents included 10.6% (N = 11) reporting 
“20-30 years,” 13.5% (N = 14) reporting “31-40 years,” 35.6% (N = 37) reporting “41-50 
years,” 32.7% (N = 34) reporting “51-60 years,” and 7.7% (N = 8) reporting “60+ years.” 
 The majority of respondents also reported having a master’s degree as the highest degree 
earned.  Specifically, 71.2% (N = 74) reported earning a master’s degree, 25.9% (N = 27) 
reported earning a doctoral degree, and 2.9% (N = 3) reported earning a clinical doctoral 
degree.  
 As medical SLPs, a majority of respondents currently provide services to patients 
with aphasia within a hospital (39.4%, N = 41), university/college clinic (37.5%, N = 39), 
or rehabilitation center (31.7%, N = 33).  Additional settings reported included skilled 
nursing facilities (9.6%, N = 10), private or group practice (9.6%, N = 10), and home 
health agencies (3.8%, N = 4).  A graph depicting the settings where survey respondents 
currently provide services can be found in Figure 2. 
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Figure 2.  Summary of Survey Respondents’ Current Settings of Practice 
 
 More than 84% (N = 88) of respondents reported being a member of an ASHA 
Special Interest Division (SID).  Specifically, 1.9% (N = 2) reported being a member of 
SID 1: Language Learning and Education, 76.9% (N = 80) reported being a member of 
SID 2: Neurophysiology and Neurogenic Speech and Language Disorders, 9.6% (N = 10) 
reported being a member of SID 3: Voice and Voice Disorders, 1.9% (N = 2) reported 
being a member of SID 4:  Fluency and Fluency Disorders, 1.0% (N = 1) reported being a 
member of SID 5: Speech Science and Orofacial Disorders, 5.8% (N = 6) reported being 
a member of SID 10: Issues in Higher Education, 11.5% (N = 12) reported being a 
member of SID 11: Administration and Supervision, 8.7% (N = 9) reported being a 
member of SID 12: Augmentative and Alternative Communication, 27.9% (N = 29) 
reported being a member of SID 13: Swallowing and Swallowing Disorders, 3.8%  
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(N = 4) reported being a member of SID 14: Communication Disorders and Sciences in 
Culturally and Linguistically Diverse (CLD) Populations, 12.5% (N = 13) reported being 
a member of SID 15: Gerontology, and 1.9% (N = 2) reported being a member of SID 16: 
School-Based Issues.   
 No respondent reported being a member of SID 6: Hearing and Hearing 
Disorders: Research and Diagnostics, SID 7: Aural Rehabilitation and Its Instrumentation, 
SID 8: Hearing Conservation and Occupational Audiology, or SID 9: Hearing and 
Hearing Disorders in Childhood.  Members of SID 2 were expected to be a large majority 
of the respondents as SID 2 was the primary source of participant recruitment.  A 
summary of respondents’ SID membership can be found in Table 9. 
 
Table 9. Summary of Survey Respondents’ ASHA SID Membership 
 
ASHA  
SID Membership 
. %  
of Respondents 
SID 1, Language Learning & Education 2 1.9% 
SID 2, Neurophysiology/Neurogenic Speech & Language Disorders 80 76.9% 
SID 3, Voice & Voice Disorders 10 9.6% 
SID 4, Fluency & Fluency Disorders 2 1.9% 
SID 5, Speech Science & Orofacial Disorders 1 1.0% 
SID 6, Hearing & Hearing Disorders: Research & Diagnostics 0 0% 
SID 7, Aural Rehabilitation & Its Instrumentation 0 0% 
SID 8, Hearing Conservation & Occupational Audiology 0 0% 
SID 9, Hearing & Hearing Disorders in Childhood 0 0% 
SID 10, Issues in Higher Education 6 5.8% 
SID 11, Administration & Supervision 12 11.5% 
SID 12, Augmentative & Alternative Communication 9 8.7% 
SID 13, Swallowing & Swallowing Disorders 29 27.9% 
SID 14, CSD in Culturally & Linguistically Diverse Populations 4 3.8% 
SID 15, Gerontology 13 12.5% 
SID 16, School-Based Issues 2 1.9% 
None 16 15.4% 
46 
 
 Eleven respondents (10.6%) reported having specialty credentials, including nine 
(8.7%) respondents with Board Certification in Neurogenics (ANCDS), one (1.0 %) 
respondent with Board Recognition in Fluency and Fluency Disorders, and one (1.0 %) 
respondent with Board Recognition in Swallowing and Swallowing Disorders.  
Additional credentials reported by respondents included Brain Injury Specialist 
Certification (N =2), Multiple Sclerosis Specialist Certification (N = 1), and Lee 
Silverman Voice Treatment (LSVT) Certification (N = 1).  
 Respondents varied widely in reporting an approximate percent of their caseload 
consisting of patients with aphasia.  Of the 104 respondents, 16.3% (N = 17) reported 
having “less than 10%” patients with aphasia, 25.0% (N = 26) reported having “About 
25%” patients with aphasia, 26.9% (N = 28) reported having “Between 33% - 66%” 
patients with aphasia, 8.7% (N = 9) reported having “About 75%” patients with aphasia, 
and 23.1% (N = 24) reported having “More than 75%” patients with aphasia.  A graph 
depicting survey respondents’ estimated percentages of caseload consisting of patients 
with aphasia can be found in Figure 3.  
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Figure 3.  Summary of Survey Respondents’ Approximate Percentage of Caseload 
Consisting of Patients with Aphasia 
 
 As would be expected, survey respondents reported varying years of practice as an 
SLP.  A majority of respondents, however, were experienced SLPs as 42.3% (N = 44) 
reported having “20+ years” experience as an SLP.  Additionally, 2.9% (N = 3) reported 
“less than 2 years” experience, 13.5% (N = 14) reported “2-5 years” experience, 11.5% 
(N = 12) reported “6-10 years” experience, 15.4% (N = 16) reported “11-15 years” 
experience, and 14.4% (N = 15) reported “16-20 years” experience.  A graph depicting 
survey respondents’ years of experience can be found in Figure 4. 
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Figure 4. Summary of Survey Respondents’ Years of Experience as an SLP 
 
 Consistent with years of practice as an SLP, a majority of respondents reported 
having “20+ years” of direct clinical experience with patients with aphasia (39.4%, N = 
41).  Additionally, 2.9% (N = 3) reported “less than 2 years” experience with aphasia, 
14.4% (N = 15) reported “2-5 years” experience with aphasia, 15.4% (N = 16) reported 
“6-10 years” experience with aphasia, 14.4% (N = 15) reported “11-15 years” experience 
with aphasia, and 13.5% (N = 14) reported “16-20 years” experience with aphasia.  A 
graph depicting survey respondents’ years of direct clinical experience with patients with 
aphasia can be found in Figure 5. 
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Figure 5. Summary of Survey Respondents’ Years of Direct Clinical Experience with 
Aphasia 
 
 Aphasia Treatment Approaches 
 Survey Question 12 asked “Which of the following treatment approaches have 
you used or recommended in the past year?”  The three most frequently reported 
treatments were Communication Partner Training (CPT) (N = 74, 71.2%), Functional 
Communication Therapy (FCT) (N = 72, 69.2%), and Promoting Aphasics’ 
Communicative Effectiveness (PACE) (N = 70, 67.3%).  The three least frequently 
reported treatments were Interactive Metronome® (IM) (N = 5, 4.8%), SentenceShaper® 
(SSR) (N = 5, 4.8%), and Sentactics® (N = 2, 1.9%).  Table 10 is a list of all treatment 
approaches included in the survey in terms of frequency of reported use.  Figure 6 
provides a visual interpretation of the reported frequency of use for these treatments. 
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Table 10.  Reported Frequency of Use for Treatment Approaches Listed in Survey 
 
Treatment Approaches . % of 
Respondents 
Communication Partner Training (CPT) 74 71.2% 
Functional Communication Therapy (FCT) 72 69.2% 
Promoting Aphasics’ Communicative Effectiveness 
(PACE) 
70 67.3% 
Augmentative and Alternative Communication (AAC) 65 62.5% 
Stimulation Approach  59 56.7% 
Melodic Intonation Therapy (MIT) 55 52.9% 
Semantic Feature Analysis (SFA) 53 51.0% 
Picture Naming Therapy  45 43.3% 
Computer Treatments 40 38.5% 
Intensive Aphasia Therapy 40 38.5% 
Response Elaboration Training (RET) 33 31.7% 
Sentence Production Program for Aphasia (formerly 
HELPSS) 
31 29.8% 
Spaced-Retrieval Training (SRT) 31 29.8% 
Constraint-Induced Aphasia Therapy (CIAT) 24 23.1% 
Treatment for Underlying Forms (TUF) 12 11.5% 
Interactive Metronome® (IM) 5 4.8% 
SentenceShaper® (SSR) 5 4.8% 
Sentactics® 2 1.9% 
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Figure 6. Reported Frequency of Use for Treatment Approaches Listed in Survey 
 
 Respondents also had the option of selecting “other” and reporting additional 
treatment approaches not explicitly listed in the survey.  Respondents reported 22 
additional treatment approaches used or recommended in the past year.  Of these 22 
additional approaches, the treatments reported by multiple respondents were Anagram, 
Copy, and Recall Therapy (ACRT), also referred to as Copy and Recall Treatment 
(CART), (N = 7, 6.7%), Oral Reading for Language in Aphasia (ORLA) (N = 4, 3.8%), 
Amer-Ind (N = 2, 1.9%), and script writing (N = 2, 1.9%).  Eighteen additional treatment 
approaches were also reported, each by a single respondent.  Table 11 is a list of the 22 
additional treatments reported in the survey in terms of frequency of reported use.  Figure 
7 provides a visual interpretation of the reported frequency of use for these treatments. 
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Table 11.  Reported Frequency of Use for “Other” Treatment Approaches Listed in 
Survey 
 
“Other” Treatment Approaches Reported . % 
 Anagram, Copy, and Recall Therapy (ACRT/CART) 7 6.7% 
Oral Reading for Language in Aphasia (ORLA) 4 3.8% 
Amer-Ind 2 1.9% 
Script Writing 2 1.9% 
Book Connection™         1 1.0% 
Cognitive-Linguistic Approaches 1 1.0% 
Cognitive Underpinnings 1 1.0% 
Cued Verb Treatment 1 1.0% 
English as a Second Language (ESL) Websites 1 1.0% 
Fluent Generative Naming 1 1.0% 
Gesture and Verbal Training (GVT) 1 1.0% 
Mapping 1 1.0% 
Multiple Oral Re-Reading (MOR) 1 1.0% 
Phonological Components Analysis (PCA)  1 1.0% 
Picture Communication Boards 1 1.0% 
Problem-Solving Approach to Spelling 1 1.0% 
Repetition Priming 1 1.0% 
Semantic Phonetic Cueing Hierarchy 1 1.0% 
Simply Smart Aphasia Therapy (SSAT)  1 1.0% 
Treatment of Aphasic Perseveration (TAPS) 1 1.0% 
Visual Action Therapy (VAT) 1 1.0% 
Verb Network Strengthening Treatment (VNeST) 1 1.0% 
 
 Prior to launching the current survey, the 18 treatment approaches included in the 
survey were categorized based on presence/absence of advertising and evidence base.  
Based on the review of practice guidelines and systematic reviews presented in the 
Practice Guidelines of the ANCDS and ASHA EBP Compendium a level of evidence was 
demonstrated by a systematic review of studies that 1) are considered to be Class II level 
of evidence or higher and 2) include an adequate number of participants to infer 
generalizability.  Also included in the survey are aphasia treatment approaches that may 
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or may not be evidence based but are advertised to clinicians.  Several professional 
magazines were reviewed for commercial advertisements and a basic Google search for 
the keywords “aphasia treatment products” and “aphasia treatment approaches” was also 
conducted in order to determine which treatments clinicians may access via a commonly-
used search engine. 
Upon respondent reporting of 22 additional treatment approaches, the 
categorization was updated to reflect these additional treatments.  Fifteen additional 
treatment approaches were reported and subsequently categorized as “evidence based and 
not advertised.” Specifically, these treatments included 1) Anagram, Copy, and Recall 
Therapy (ACRT), 2) Amer-Ind, 3) cognitive-linguistic approaches, 4) cued verb 
treatment, 5) fluent generative naming, 6) Gesture and Verb Training (GVT), 7) mapping, 
8) Multiple Oral Re-Reading (MOR), 9) Oral Reading for Language in Aphasia (ORLA), 
10) Phonological Components Analysis (PCA), 11) picture communication boards, 12) 
script writing, 13) semantic phonetic cueing hierarchy, 14) Treatment of Aphasic 
Perseveration (TAPS), and 15) Visual Action Therapy (VAT).   
Of the additional treatment approaches reported and considered to not have a 
significant evidence base, two additional treatment approaches were reported and 
categorized as “no/limited evidence base and advertised.”  These treatments included the 
use of 1) Book Connection™ and 2) English as a second language (ESOL) Websites.  
Five additional treatment approaches were reported and categorized as “no/limited 
evidence base and not advertised.”  These treatments included 1) cognitive 
underpinnings, 2) problem-solving approach to spelling, 3) repetition priming, 4) Simply 
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Smart Aphasia Therapy (SSAT), and 5) Verb Network Strengthening Treatment 
(VNeST).  A summary of treatment approach categorization, including the additional 
treatments identified by respondents, can be found in Table 12.  
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Table 12. Summary of Treatment Approach Categorization, Including Additional 
Treatments Identified During Survey Completion, Based on Advertising and Evidence 
 
 Evidence Base 
+ 
.o/Limited Evidence Base 
-- 
 
 
 
Advertised 
 
 + 
1. Augmentative and Alternative 
Communication (AAC) (e.g., DynaVox®; 
Say-it! SAM Communicator) 
2. Picture Naming Therapy (e.g., picture 
naming kits) 
3. Stimulation Approach 
1. Book Connection™ 
2. Computer Treatments  
3. English as a Second 
Language (ESL) Websites 
4. Interactive Metronome ® 
5. Sentactics® 
6. SentenceShaper® 
 
 
 
 
 
 
 
 
 
 
 
.ot  
 
Advertised 
 
˗˗ 
1. Anagram, Copy, & Recall Therapy 
(ACRT) 
2. Amer-Ind 
3. Cognitive-Linguistic Approaches 
4. Communication Partner Training (CPT)  
5. Constraint-Induced Aphasia Therapy 
(CIAT) 
6. Cued Verb Treatment 
7. Fluent Generative Naming 
8. Functional Communication Therapy 
(FCT) 
9. Gesture and Verbal Training (GVT) 
10. Intensive Aphasia Therapy 
11. Mapping 
12. Melodic Intonation Therapy (MIT) 
13. Multiple Oral Re-Reading (MOR) 
14. Oral Reading for Language in Aphasia 
(ORLA) 
15. Phonological Components Analysis (PCA) 
16. Picture Communication Boards 
17. Promoting Aphasics’ Communicative 
Effectiveness (PACE) 
18. Response Elaboration Training (RET) 
19. Script writing 
20. Semantic Feature Analysis (SFA) 
21. Semantic Phonetic Cueing Hierarchy 
22. Sentence Production Program for Aphasia  
23. Spaced-Retrieval Training (SRT) 
24. Treatment of Aphasic Perseveration 
(TAPS) 
25. Treatment for Underlying Forms (TUF) 
26. Visual Action Therapy (VAT) 
 
1. Cognitive Underpinnings 
2. Problem-Solving Approach 
to Spelling 
3. Repetition Priming 
4. Simply Smart Aphasia 
Therapy (SSAT) 
5. Verb Network 
Strengthening Treatment 
(VNeST) 
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 Perceived Levels of Evidence 
Survey Question 13 asked “How strong do you believe the evidence to be for each 
approach you selected in Question 12?”  It is important to note that not all respondents 
reporting to have used or recommended a treatment in the past year provided a perceived 
level of evidence for that treatment.  Similarly, some respondents reported perceived 
levels of evidence for treatments which they did not report using or recommending in the 
past year.  Therefore, only data for treatments reported to have been used or 
recommended in the past year (Question 12) were included in data analysis.  
The treatment approaches perceived as having “minimal” evidence by the 
majority of respondents (i.e., ≥50%) included stimulation approach (56.1%), picture 
naming therapy (50.0%), and the Sentence Production Program for Aphasia (50.0%).  Of 
the 22 additional treatment approaches not explicitly included in the survey but reported 
to be used by respondents, Oral Reading for Language in Aphasia (ORLA) (50.0%) and 
Amer-Ind (100%) are also perceived as having “minimal evidence.”  A summary of the 
treatment approaches perceived as having “minimal evidence” can be found in Table 13. 
 
Table 13. Treatment Approaches Perceived as Having “Minimal Evidence” 
 
Treatment Approaches Rated 
“Minimal Evidence” 
. / Total % of Respondents 
Rating 
“Minimal Evidence” 
Stimulation Approach 23 / 41 56.1% 
Picture Naming Therapy 18 / 36 50.0% 
Sentence Production Program for Aphasia 13 / 26 50.0% 
Other 
         Oral Reading for Language in Aphasia 
         Amer-Ind 
 
2 / 4 
1 / 1 
 
50.0% 
100% 
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The treatment approaches perceived as having “moderate” evidence by the 
majority of respondents (i.e., ≥50%) included Treatment for Underlying Forms (TUF) 
(81.8%), Semantic Feature Analysis (SFA) (73.9%), Spaced-Retrieval Training (SRT) 
(57.7%), Promoting Aphasics’ Communicative Effectiveness (PACE) (52.1%), 
Communication Partner Training (CPT) (50.8%), and Constraint-Induced Aphasia 
Therapy (CIAT) (50.0%).  Of the additional treatment approaches reported to be used by 
respondents, script writing (100%) and Anagram, Copy, and Recall Therapy (ACRT) 
(50.0%) are also perceived as having “moderate evidence.”  A summary of the treatment 
approaches perceived as having “moderate evidence” can be found in Table 14. 
 
Table 14. Treatment Approaches Perceived as Having “Moderate Evidence” 
 
Treatment Approaches Rated  
“Moderate Evidence” 
. / Total % of Respondents 
Rating  
“Moderate Evidence” 
Treatment for Underlying Forms (TUF) 9 / 11 81.8% 
Semantic Feature Analysis (SFA) 34 / 46 73.9% 
Spaced-Retrieval Training (SRT) 15 / 26 57.7% 
Promoting Aphasics’ Communicative 
Effectiveness (PACE) 
25 / 48 52.1% 
Communication Partner Training (CPT) 32 / 63 50.8% 
Constraint-Induced Aphasia Therapy 
(CIAT) 
8 / 16 50.0% 
Other 
         Scripts 
         Anagram, Copy, and Recall Therapy  
          (ACRT/CART)   
 
2 / 2 
3 / 6 
 
100% 
50.0% 
 
Each treatment approach had a small percentage of respondents perceiving it to 
have “no/limited evidence” and a small percentage of respondents perceiving it to have 
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“strong evidence.”  No treatment approach had a majority of respondents perceiving it to 
have “no/limited evidence.”  The only treatment approach perceived as having a “strong” 
level of evidence was the Interactive Metronome® (IM) with 100% of respondents rating 
it as having “strong evidence.”  However, it is important to note that only two 
respondents provided a level of evidence for this treatment approach.   
All remaining treatment approaches had a majority of respondents (i.e., ≥50%) 
reporting between “minimal evidence” to “moderate evidence.”  Specifically, these 
treatment approaches included SentenceShaper® (100%), Melodic Intonation Therapy 
(MIT) (88.6%), computer treatments (86.7%), augmentative and alternative 
communication (AAC) (84.9%), Functional Communication Therapy (FCT) (82.5%), 
Response Elaboration Training (RET) (76.0%), and intensive aphasia therapy (72.2%).  A 
summary of the treatment approaches perceived as having “minimal” or “moderate” 
evidence can be found in Table 15. 
 
Table 15. Treatment Approaches Perceived as Having “Minimal” to “Moderate” 
Evidence 
 
Treatment Approaches Rated  
“Minimal” to “Moderate” Evidence 
. / Total % of Respondents Rating  
“Minimal” or “Moderate” 
Evidence 
SentenceShaper® 4 / 4 100% 
Melodic Intonation Therapy (MIT) 39 / 44 88.6% 
Computer Treatments 26 / 30 86.7% 
Augmentative and Alternative 
Communication (AAC) 
45 / 53 84.9% 
Functional Communication Therapy 
(FCT) 
52 / 63 82.5% 
Response Elaboration Training (RET) 19 / 25 76.0% 
Intensive Aphasia Therapy 39 / 54 72.2% 
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 Sources of Information 
 Survey Question 14 asked “What has been your primary means of attaining 
information regarding each approach you selected in Question 12?”  It is important to 
note that not all respondents reporting to have used or recommended a treatment in the 
past year provided a primary source of information for that treatment.  Similarly, some 
respondents reported sources of information for treatments that were not reported to be 
used or recommended in the past year.  Therefore, only sources of information for 
treatments reported to have been used or recommended in the past year (Question 12) 
were included in data analysis. 
 The most frequently reported sources of information were professional journals 
(N = 180, 31.6%), graduate school (N = 174, 30.5%), conferences (N = 88, 15.4%), and 
colleague (N = 76, 13.3%).  The least frequently reported sources of information were 
magazines (N = 9, 1.6%) and advertisements (N = 4, 0.7%).  Respondents selected 
“other” as their primary sources of information in 6.8% of responses (N = 39).  However, 
due to the limitations of the survey software used, no additional information was able to 
be obtained regarding these additional sources of information.  A summary of the 
frequency of sources of information reported can be found in Figure 7. 
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Figure 7. Summary of Frequency of Sources of Information Reported 
 
 The treatment approaches reported as having “Graduate School” as the primary 
source of information by the majority of respondents (i.e., ≥50%) included stimulation 
approach (70.5%), picture naming therapy (65.6%), and Melodic Intonation Therapy 
(MIT) (53.3%).  A summary of the treatment approaches reportedly learned in graduate 
school can be found in Table 16. 
 
Table 16. Treatment Approaches Learned in Graduate School 
 
Treatment Approaches With 
“Graduate School”  
As Primary Source of Information 
. / Total % of Respondents Selecting  
“Graduate School”  
As Primary Source 
Stimulation Approach 31 / 44 70.5% 
Picture Naming Therapy 21 / 32 65.6% 
Melodic Intonation Therapy (MIT) 24 / 45 53.3% 
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The treatment approaches reported as having “Professional Journal” as the 
primary source of information by the majority of respondents (i.e., ≥50%) included 
Treatment For Underlying Forms (TUF) (83.3%), Semantic Feature Analysis (SFA) 
(55.6%), Constraint-Induced Aphasia Therapy (CIAT) (50.0%), and SentenceShaper® 
(50.0%).   Of the additional treatment approaches reported to be used by respondents, 
script writing (50.0%) and Anagram, Copy, and Recall Therapy (ACRT) (50.0%) were 
also reported to be learned through professional journals.  A summary of the treatment 
approaches reportedly learned through professional journals can be found in Table 17. 
 
Table 17. Treatment Approaches Learned Through Professional Journals 
 
Treatment Approaches With 
“Professional Journal” 
As Primary Source of Information 
. / Total % of Respondents Selecting 
“Professional Journal”  
As Primary Source 
Treatment For Underlying Forms (TUF) 10 / 12 83.3% 
Semantic Feature Analysis (SFA) 25 / 45 55.6% 
Constraint-Induced Aphasia Therapy 
(CIAT) 
8 / 16 50.0% 
SentenceShaper® 2 / 4 50.0% 
Other 
        Anagram, Copy, and Recall Therapy 
        Script Writing 
 
2 / 4 
1 / 2 
 
50.0% 
50.0% 
 
 Both “advertisement” and “magazine” were infrequently selected as the primary 
source of information.  The only treatment approaches with any respondent reporting 
“advertisement” as their primary means of attaining information included computer 
treatments (N = 3, 9.4%) and intensive aphasia therapy (N = 1, 3.1%).  The only 
treatment approaches with any respondent reporting “magazine” as their primary source 
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of information included Communication Partner Training (CPT) (N = 2, 3.2%), 
Functional Communication Therapy (FCT) (N = 2, 3.3%), Promoting Aphasics’ 
Communicative Effectiveness (PACE) (N = 1, 2.2%), Semantic Feature Analysis (SFA) 
(N = 2, 4.4%), computer treatments (N = 1, 3.1%), and Constraint-Induced Aphasia 
Therapy (CIAT) (N = 1, 6.3%).   
 
Exposure Prior to Use 
 Survey Question 15 asked “Looking back, how much time would you estimate 
passed between when you first learned of each approach and when you first used it in 
practice?”  It is important to note that not all respondents reporting to have used or 
recommended a treatment in the past year provided a time period for that treatment.  
Similarly, some respondents reported time periods for treatments that they did not 
indicate as using or recommending in the past year.  Therefore, only time periods for 
treatments reported to have been used or recommended in the past year (Question 12) 
were included in data analysis. 
Based on results of Question 15, it appears as though clinicians implement 
treatment approaches rather quickly after learning the protocols and gathering the 
necessary materials. Overall, respondents reported that they implemented most of the 
treatment approaches included in the survey within “0-3 months” of exposure of each 
approach.  Treatments reportedly implemented within “0-3 months” of exposure by a 
majority of respondents (i.e., ≥50%) included picture naming therapy (84.6%), 
stimulation approach (80.0%), Functional Communication Therapy (FCT), (74.1%), 
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Communication Partner Training (CPT) (63.2%), Constraint-Induced Aphasia Therapy 
(CIAT) (61.5%), computer treatments (60.7%), Semantic Feature Analysis (SFA) 
(60.5%), Promoting Aphasics’ Communicative Effectiveness (PACE) (60.0%), Spaced-
Retrieval Training (SRT) (59.1%), Sentence Production Program for Aphasia (57.1%), 
Response Elaboration Training (RET) (50.0%), and Sentactics® (50.0%).  Of the 
additional treatment approaches reported by respondents, Anagram, Copy, and Recall 
Therapy (ACRT) (100%), Oral Reading for Language in Aphasia (ORLA) (100%), and 
script writing (100%) were also reported to be used within “0-3 months” of exposure.  A  
summary of the treatments reportedly used within three months can be found in Table 18.  
 
Table 18. Treatment Approaches Implemented Within Three Months of Exposure 
 
Treatment Approaches Reported to be 
Implemented Within “0-3 Months” of Exposure 
. / 
Total 
% of Respondents 
Selecting “0-3 
Months” 
Picture Naming Therapy 22 / 26 84.6% 
Stimulation Approach 32 / 40 80.0% 
Functional Communication Therapy (FCT) 40 / 54 74.1% 
Communication Partner Training (CPT) 36 / 57 63.2% 
Constraint-Induced Aphasia Therapy (CIAT) 8 / 13 61.5% 
Computer Treatments 17 / 28 60.7% 
Semantic Feature Analysis (SFA) 23 / 38 60.5% 
Promoting Aphasics’ Communicative Effectiveness 
(PACE) 
24 / 40 60.0% 
Spaced-Retrieval Training (SRT) 13 / 22 59.1% 
Sentence Production Program for Aphasia 12 / 21 57.1% 
Response Elaboration Training (RET) 12 / 24 50.0% 
Sentactics® 1 / 2 50.0% 
Other 
         Anagram, Copy, and Recall Therapy (ACRT) 
         Oral Reading for Language in Aphasia (ORLA) 
         Scripts 
 
3 / 3 
3 / 3 
1 / 1 
 
100% 
100% 
100% 
 
64 
 
 Although the remaining treatment approaches did not have a majority of 
respondents (i.e., ≥50%) reporting implementation within “0-3 months” of exposure, a 
substantial number of respondents did report “0-3” months for these treatments.  These 
treatments included augmentative and alternative communication (AAC) (49.0%), 
intensive aphasia therapy (48.1%), Melodic Intonation Therapy (MIT) (39.5%), and 
Treatment for Underlying Forms (TUF) (30.0%).  The only treatments with a significant 
number of respondents not reporting implementation within “0-3 months” were 
Interactive Metronome® (50% reporting “4-6 months” and 50% reporting “6-9 months”) 
and SentenceShaper® (33.3% reporting “4-6 months,” “9-12 months,” and “>12 
months”).   
 Survey Question 16 asked “What factors have contributed to the time lag between 
exposure to and use of treatment approaches?”  The most frequently reported response 
was “Did not have appropriate client/caseload for the treatment” with 59.6% (N = 62) of 
respondents selecting this reason.  The least frequently reported response was “Materials 
for the treatment could not be purchased” with 13.5% (N = 14) of respondents selecting 
this reason.  Additional factors reported to contribute to the time lag between exposure 
and use included “Wanted to learn more about the procedures of the treatment” (N = 36, 
34.6%), “Wanted to review the evidence base for the treatment” (N = 28, 26.9%), “Time 
required to gather materials necessary for the treatment” (N = 27, 26.0%), and “Wanted to 
ask colleagues’ opinions of the treatment” (N = 21, 20.2%).  A summary of factors 
reported to contribute to the time lag between exposure to and implementation of 
treatment approaches can be found in Figure 8. 
65 
 
 
Figure 8. Summary of Factors Reported to Contribute to the Time Lag Between Exposure 
and Implementation of Treatment Approaches for Aphasia 
 
 Implementation 
Section VI consisted of two open-ended questions (Questions 17 and 18) allowing 
respondents to provide unrestricted explanations related to their use of EBP.  Before 
responses could be coded for trend analysis purposes, responses had to be broken down 
into comments related to separate ideas.  Following a preliminary review of the 
responses, a panel of three expert reviewers developed coding guidelines in order to 
enhance inter-judge reliability.  Two of these reviewers were doctorate-level university 
faculty members with current state licensure and the CCC-SLP.  The third reviewer was 
the principle investigator of this study and a master’s-level student within the Department 
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of Communication Sciences and Disorders at the university where the survey was 
developed.  Based on the panel’s discussion, coding rules were developed as follows: 
1) Comments were to be broken up only at sentence boundaries, which included a 
period followed by a capital letter, a comma followed by a capital letter, or no 
punctuation but two continuous phrases with the second phrase beginning with a 
capital letter.  
2) Sentences were to be broken up (as defined above) when each sentence seemed to 
address a different topic.  
3) More than one continuous sentence that included cohesive ties or other inter-
sentential markers that linked the topic across sentences were to be preserved as 
one thematic statement. 
4) Single sentences that included lists of items marked by commas were not to be 
broken up. 
Following establishment and implementation of these coding rules, inter-judge 
reliability in comment dissection reached 100%.  Ultimately, 80 comments were 
identified for Question 17 and 79 comments were identified for Question 18. 
The same three judges then independently established preliminary trends related 
to each question.  Preliminary trends were discussed by all three reviewers and a 
consensus was reached on final master trends for coding regarding each question.  Using 
these master trends, each judge independently assigned one alphabetic code to each 
comment.  Upon review, if two of the three judges assigned the same code to a comment, 
that code was accepted as the trend identified.  If all three judges provided a different 
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code for a comment, the comment was discussed in further detail until an agreement was 
reached.  Three comments required further discussion, and due to the ambiguity of these 
comments were eliminated from further analysis. 
Survey Question 17 asked “What would facilitate your increased use of evidence-
based practice related to your patients with aphasia?”  Although the wording varied 
considerably among responses, the panel of three judges identified five master trends 
repeated throughout responses.  These trends can be found in Table 19.  
 
Table 19. Identified Trends and Corresponding Subtrends for Question 17 
 
Master Trends Subtrends 
Increased ease of access to information 1)  Need for Web-based access 
2)  Difficulty accessing information since  
     leaving graduate school 
Need for practice-based evidence 1)  Need for practice-based research 
2)  Need for evidence related to specific  
     populations 
3)  Need for more practice guidelines 
4)  Need for standard protocols 
Allocation of financial resources 1)  Lack of funding 
2)  Lack of financial resources for materials 
3)  Limited resources 
Lack of time 1)  Limited time to research evidence base 
2)  Work setting time constraints 
Non-codable/irrelevant comments  
 
The trend most frequently supported by respondents’ comments was a desire for 
increased ease of access to information.  Of the 80 comments identified for this question, 
36 (45%) comments reflected a desire for improved accessibility to evidence-based 
information.  Subtrends which reflected this trend included a desire for free access to 
68 
 
information, a need for more Web-based access, desire for broader dissemination of 
information regarding specific treatment approaches, a desire for synthesized evidence-
based reviews, and difficulty accessing evidence-based information since leaving 
graduate school.   
In support of this trend, one respondent reported a desire for “easy and free access 
to meta-analyses of treatment approaches that include both report of efficacy, step-by-step 
instructions for implementing including suggestions for measuring both acquisition and 
impact data.”  Another respondent reported the need for “having the information available 
from reputable sources in a format other than journal articles, which can be time 
consuming to read and interpret.”   
The second most frequently reported trend was a need for practice-based 
evidence.  Of the 80 comments identified, 23 (28.8%) comments reflected the need for 
practice-based evidence.  Subtrends associated with this trend included a need for 
research applicable to “real world” situations and specific populations, development of 
evidence-based standard protocols, and development of more practice guidelines.  For 
example, one respondent reported a desire for “more studies which incorporate 
individuals who have complex medical histories than those which are typically presented 
in the studies which inform evidence-based practice.”  Another respondent reported a 
need for “greater specificity in published studies as to the protocols followed in 
treatment.” 
Consistent with a review of the literature regarding barriers to EBP, several 
respondents reported the allocation of financial resources and lack of professional time to 
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impede their use of EBP.  Eight (10.0%) comments reflected a lack of funding for 
continuing education, lack of financial resources for materials, or limited resources for 
EBP implementation.  Similarly, seven (8.8%) comments reflected limited time to 
research the evidence base as well as other work setting time constraints.  One respondent 
stated that time limitations require him/her to depend on “articles that interpret and 
summarize the research to help me determine whether to try something versus being 
given the details of the study” but acknowledges that “depending on someone else to 
determine if it is a solid study and findings is risky.”  
Suggestions for the facilitated use of evidence-based practice related to the 
treatment of patients with aphasia included free Webinars, a more user-friendly ASHA 
Website, and development of an easily digested compendium of evidence, such as a 
handbook, manual, or Web-based source.  One respondent creatively suggested a 
“Therapy of the Month” e-mail that could briefly and succinctly describe a treatment’s 
protocol and evidence base.   
Finally, six (7.5%) comments were considered to be non-codable or irrelevant 
comments.  Such comments included statements that the individual already implements 
EBP in their clinical decision making as well as statements describing the current 
credentials or awards of continuing education (ACE) held by the individual.  A summary 
of the trend analysis for Question 17 can be found in Table 20.  A visual representation of 
this trend analysis can be found in Figure 9.  
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Table 20.  Summary of Trends Identified as Affecting Use of EBP with Patients with 
Aphasia 
 
Trend Category Comments Identified % of Comments 
Increased ease of access to 
information 
36 45.0% 
Need for practice-based information 23 28.8% 
Allocation of financial resources 8 10.0% 
Lack of time 7 8.8% 
Non-codable/Irrelevant 6 7.5% 
  
 
Figure 9.  Summary of Trends Identified as Affecting Use of EBP with Patients with 
Aphasia 
 
Survey Question 18 asked respondents to “Describe situations which prompted 
you to seek and implement alternative approaches for patients with aphasia.”  Originally, 
79 comments were identified for this question.  However, three comments could not be 
agreed upon during the coding process due to ambiguity and were eliminated from 
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analysis.  The panel of three judges identified six master trends repeated throughout 
responses.  These trends can be found in Table 21.  
 
Table 21. Identified Trends and Corresponding Subtrends for Question 18 
 
Master Trends Subtrends 
Lack of treatment success 1)  Treatment failure 
2)  Wanted to make treatment more functional 
Challenging diagnoses 1)  Unique/rare diagnoses 
2)  Specific populations 
3)  Chronic aphasia 
Interest in a new treatment 
approach 
1)  Interest following a review of the evidence 
2)  Interest following conference/workshop/colleague 
Client need 1)  Need for individualized treatment 
2)  Client dissatisfied with previous treatment outcome 
3)  Client preference 
Clinician expertise 1)  Clinician’s desire to improve own skill level 
Non-codable/Irrelevant  
 
The trend which most frequently prompted the respondents to seek and implement 
an alternative treatment for aphasia was lack of treatment success.  Of the 76 comments 
identified for this question, 28 (36.8%) comments reflected a need for an alternative 
approach because of treatment failure, lack of anticipated success, or a need to make 
treatment more functional for the patient.  For example, one respondent commented, 
“When I have a client who is not responding to ‘traditional’ treatment, I will seek out 
journal articles about treatments related to the client’s needs.”   
Another frequently reported trend which prompted an alternative treatment 
approach was simply client need which included client dissatisfaction, client preference, 
varying needs based on the recovery process, and need for individualization of treatment. 
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 Of the 76 comments, 19 (25.0%) reflected client-driven reasons for alternative treatment 
implementation.  For example, one respondent stated, “I tailor my treatments to the client 
needs and personalize according to the individual’s background; When I do not have the 
approach that addresses the deficit and client, I seek other approaches.”  Another 
respondent described using an alternative treatment when treatment is based on 
“transitioning the client to personally relevant participation and activity based tasks that 
need task analysis and situational modification.”  
Several respondents also reported comments which reflected a challenging 
diagnosis as the catalyst for implementing alternative treatment approaches for aphasia.  
Specifically, 13 (17.1%) comments described using alternative approaches for unique 
and/or rare diagnoses and specific populations of patients with unique needs.  For 
example, one respondent commented, “When I see a client with a less frequent diagnosis, 
e.g. PPA, I often review the literature and assure that I have considered all options and 
alternatives.”  Many comments also reflected the need to seek alternative treatments for 
patients with chronic aphasia.  Specific populations which prompted alternative 
treatments included bilingual or multicultural patients, patients with limited education, 
and hearing and/or visually impaired patients with aphasia.   
Five (6.6%) respondents provided a comment reflecting implementation of an 
alternative treatment approach following exposure to a new treatment.  Interest was 
typically initiated following a literature review indicating promise in a treatment or after 
exposure to the treatment through a conference, workshop, or colleague.  For example, 
one respondent state, “Sometimes it was the lure of something new and different that 
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prompted some experimentation; Sometimes the mention of a new approach by a 
colleague or mentor prompted the change.”   
Five (6.6%) comments indicated that clinician expertise was the driving force 
behind implementation of an alternative treatment.  Comments generally reflected the 
clinician’s desire to improve their own skill level through knowledge of alternative 
approaches, such as “I want to be as effective as I can to help my patients.” 
Finally, 6 (7.9%) comments were considered to be non-codable or irrelevant 
comments.  Such comments included statements that reflected respondents’ confusion of 
the question and statements that did not relate to the question.  A summary of the trend 
analysis for Question 17 can be found in Table 22. A visual representation of trend 
analysis can be found in Figure 10.  
 
Table 22.  Summary of Trends Identified as Prompting Alternative Treatments 
Approaches to Aphasia 
 
Trend Category Comments Identified % of Comments 
Lack of treatment success 28 36.8% 
Client need 19 25.0% 
Challenging diagnoses 13 17.1% 
Interest in a new treatment approach 5 6.6% 
Clinician expertise 5 6.6% 
Non-codable/Irrelevant 6 7.9% 
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Figure 10. Summary of Trends Identified as Prompting Alternative Treatment 
Approaches to Aphasia 
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CHAPTER FOUR: 
CONCLUSION AND DISCUSSION 
 The current study investigated issues regarding the use of evidence-based practice 
(EBP) in the clinical decision-making of aphasia therapy.  Web-based and hard copy 
versions of an 18-question survey were created in an attempt to build our understanding 
of the potential research-to-practice gap in the treatment of neurological communication 
disorders.  The current study addressed the following research questions:  
1. Do current clinicians of neurogenic communication disorders implement 
evidence-based practices? 
2. Where are clinicians obtaining information regarding the practices they are 
implementing? 
3. Are the perceptions of what clinicians believe to be evidence-based in accordance 
with available practice guidelines? 
4. How much time typically passes between when a clinician is first exposed to and 
when he/she first implements different treatment approaches? 
5. What factors contribute to the lag in time between exposure to and 
implementation of treatment approaches? 
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Results of the current study extend the findings of previous studies regarding the 
perceptions and implementation of EBP within aphasia therapy.  Results indicate that 
many of the common treatment approaches for aphasia currently in practice are evidence 
based.  However, a research-to-practice gap exists as clinicians are not reportedly 
implementing many additional treatment approaches also supported by evidence.  
Similarly, clinicians’ perceptions of what is evidence based are not always in accordance 
with current practice guidelines.  Clinicians appear to rely on professional journals, 
graduate school training, and professional conferences as their primary sources of 
evidence-based information.  It does not appear as though advertising significantly affects 
clinicians’ decision making in treatment selection.  Furthermore, clinicians tend to 
implement new or alternative treatment approaches rather quickly after exposure to the 
treatment.  Possible contributing factors and clinical implications of these findings are 
discussed below.  
 
Response Rate 
 According to Blair and Czaja (2005), “The questionnaire is the indispensible 
means by which the opinions, behaviors, and attributes of respondents are converted into 
data,” (p.122).  However, survey research has a history of being plagued by poor response 
rates.  According to Babbie & Rubin (2000), a response rate of 50% is considered 
adequate for analysis and reporting purposes, a response rate of 60% is considered good, 
and a response rate of 70% is considered very good.   
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 Of the estimated 4,500 potential respondents contacted via the American Speech-
Language-Hearing Association (ASHA) Special Interest Division 2 listserve, the state 
representatives’ e-mail listserv of the National Aphasia Association (NAA) database, and 
monthly meetings of the Tampa Bay Medical Speech Pathology Association (MESPA) 
during the recruitment period, 117 responses were obtained.  This corresponds with a 
response rate of approximately 2.6%.  Although this response rate is considerably below 
the recommended response rate of Babbie & Rubin (2000), the demographics of the 
current study parallels that of the ASHA 2009 Health Care Survey.  Therefore, the 
decision was made to analyze the data in an attempt to answer the research questions 
proposed in the current study.  
 Factors that may have contributed to this low response rate include e-mails going 
directly to “junk mail,” respondents not recognizing the sender and deleting the 
recruitment e-mail, clinicians not responding to the survey within the data collection time 
period, and clinicians forgetting to return to the survey link after receiving the recruitment 
e-mail.  Participation may have been improved by sending a second recruitment e-mail. 
 
Demographic Representation 
 Respondents of the current study appear to be representative of the greater 
medical speech-language pathology (SLP) community. The demographic composition of 
survey respondents in the current study reflects the demographic composition of medical 
SLPs in the United States as reported in the ASHA 2009 Health Care Survey.  The ASHA 
Health Care Survey is a biennial report probing current issues affecting SLPs working in 
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health care, such as caseload, shortages, salaries, and productivity (Brown, 2009).  Both 
the ASHA 2009 Health Care Survey and the current survey, therefore, recruited similar 
participants as clinicians working in health care settings are the primary providers of 
rehabilitation services to patients with aphasia.   
 Of the 2,064 SLPs (a response rate of 54.6%) who completed the ASHA 2009 
Health Care Survey, 95% of respondents were female and 5% were male, similar to the 
gender distribution of the current study (i.e., 92% female, 8% male).  In accordance with 
the primary employment facilities reported by respondents of the current study, 
respondents of the ASHA 2009 Health Care Survey reported clinics (29%), skilled 
nursing facilities (23%), and general medical hospitals (20%) as the facilities where most 
of the respondents worked.  The majority of respondents to ASHA’s survey reported 
having a master’s degree, and the mean age of SLPs who participated in the survey was 
44.  This is consistent with the education level and age range of the majority of 
participants in the current study.  The mean years of experience reported by ASHA survey 
respondents was 15 years, slightly less than was reported in the current study (i.e., 42% 
reporting 20+ years experience).   
 The current study did not probe responses related to salary basis, ethnicity, race, 
population density, or geographic distribution and, therefore, could not be compared to 
these demographic characteristics of ASHA survey respondents.  However, since the 
current survey was electronically sent to SLPs throughout the United States, it is assumed 
that additional demographic characteristics would reflect the demographic composition of 
the greater medical SLP community. 
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The clinical findings of the current study are discussed below as they relate to the 
research questions proposed and the current evidence base. Additionally, the scope and 
limitations of the current study are discussed.  Finally, future directions for research are 
recommended.  
 
Current Implementation of Evidence-Based Treatments 
Research Question 1 asked “Do current clinicians of neurogenic communication 
disorders implement evidence-based practices?”  Of the treatment approaches listed in the 
survey, the three most frequently reported treatments were Communication Partner 
Training (CPT), Functional Communication Therapy (FCT), and Promoting Aphasics’ 
Communicative Effectiveness (PACE).  All three of these treatments meet the 
predetermined level of evidence as demonstrated by a systematic review of studies that 1) 
are considered to be Class II level of evidence or higher and 2) include an adequate 
number of participants to infer generalizability.  Furthermore, every treatment reported by 
a majority of respondents (i.e., >50%) to have been used or recommended within the past 
year met this study’s criteria for having an evidence base.   
Given Robey’s (1998) meta-analysis, stimulation approach is considered 
evidence-based for the purposes of this study.  However, there are some concerns 
regarding whether or not this approach is truly evidence based as stimulation therapy is 
poorly defined.  Unlike other treatments, stimulation therapy lacks specific procedures, 
and it is unclear as to what actually constitutes stimulation therapy.   It remains 
questionable whether using various workbook exercises really holds true to the important 
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components of a stimulation approach (i.e., exposing patients to tasks that will 
“stimulate” functioning of compromised linguistic modalities).  
Unfortunately, seven treatment approaches to aphasia that are considered evidence 
based were not reported to have been used or recommended in the past year by a majority 
of respondents.  Specifically, these treatments included intensive aphasia therapy, picture 
naming therapy, Response Elaboration Training (RET), Sentence Production Program for 
Aphasia (formerly HELPSS), Spaced-Retrieval Training (SRT), Constraint-Induced 
Aphasia Therapy (CIAT), and Treatment for Underlying Forms (TUF).   
Although each of these treatments has empirical data to support their use, these 
treatments do not appear to be commonly used treatments for aphasia in current practice.  
Ironically, with the exception of picture naming therapy and Sentence Production 
Program for Aphasia (SPPA), respondents perceive these treatments as having a moderate 
amount of evidence.  This prompts the question:  If clinicians perceive these treatments to 
be evidence based, why are they not implementing them in their clinical practices?  
Possible reasons for non-use of evidence-based treatments may include: the facility by 
which the clinician is employed does not own the necessary materials for the treatment, 
limited financial resources to purchase required materials, or lack of an appropriate 
candidate for the treatment.  Clinicians may also be relying on personal experiences and 
continuing to use treatments they have found effective rather than attempting additional 
treatments.  Furthermore, because many respondents indicated graduate school as a 
primary source of information, non-use of these treatments may reflect the limited 
exposure to these treatments during their graduate training programs. 
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Interestingly, with the exception of stimulation therapy materials, none of the 
advertised treatments explicitly included in the survey (i.e., Interactive Metronome ®, 
Sentactics®, SentenceShaper®) were reported to be used or recommended by a majority 
of respondents.  Similarly, advertised computer treatments (e.g., Parrot Software®, 
Bungalow Software®, Lingraphica®) were also not used or recommended by a majority.  
Therefore, it does not appear that clinicians are highly persuaded by advertising to 
implement commercially available aphasia treatments.  However, because several 
respondents indicated a lack of financial resources as a deterrent from attempting 
alternative treatment approaches, it may be that clinicians are not using these advertised 
products due to financial barriers rather than the perception of the evidence base for these 
products.  Although many of these products offer user testimonials or provide financial 
compensation to spokespersons within the field, they lack empirical data to be considered 
evidence based.  
Four additional treatment approaches not included in the survey were reported to 
have been used or recommended by multiple respondents in the past year including 
Anagram, Copy, and Recall Therapy (ACRT), Oral Reading for Language in Aphasia 
(ORLA), Amer-Ind, and script writing.  All four of these treatments were classified as 
having an evidence base and are not advertised.  In contrast, all additional treatments 
reported to have been used or recommended by a single respondent (i.e., cognitive 
underpinnings, problem-solving approach to spelling, repetition priming, Simply Smart 
Aphasia Therapy, Verb Network Strengthening Treatment, Book Connection™, and  
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English as a Second Language Websites) are considered to have no/limited evidence base 
and are a mixture of advertised products and non-advertised treatments.  
Interest in EBP has increased significantly in the past three decades (Zipoli & 
Kennedy, 2005).  This is particularly true in the past 10 years with the creation of 
evidence-based sources of information such as the ASHA EBP Compendium and the 
Academy of Neurologic Communication Disorders and Sciences (ANCDS) compendium 
of practice guidelines.  ASHA has also endorsed EBP at the graduate training level by 
promoting use of the Knowledge and Skills Acquisition (KASA) summary form.  
However, has a push for use of EBP changed the clinical decision-making in aphasia 
therapy?  Is there a difference in the treatments used by clinicians practicing 10 years or 
less?   
Preliminary findings of the current study support the idea that the majority of non-
evidence based treatments for aphasia are primarily implemented by clinicians practicing 
10 years or more.  Specifically, Book Connection™, computer treatments (e.g., Parrot 
Software, Bungalow Software, Lingraphica), English as a second language (ESL) 
website, Interactive Metronome® (IM), Sentence Shaper®, cognitive underpinnings, 
problem-solving approach to spelling, and Simply Smart Aphasia Therapy (SSAT) are 
primarily used by clinicians with 10 or more years of direct experience with patient’s with 
aphasia.  Furthermore, no respondent practicing 2 years or less reported using any non-
evidence based treatment.  This may reflect emphasis of EBP by graduate training 
programs, or it may simply reflect the fact that beginning clinicians participating in the 
study have not yet been exposed to these non-evidence based treatments.  
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In summary, clinicians of neurogenic communication disorders are implementing 
evidence-based treatment approaches.  However, many additional evidence-based 
treatments (e.g., constraint-induced aphasia therapy, spaced-retrieval training, intensive 
aphasia therapy) are not reportedly used in current practices by a majority of respondents. 
 Furthermore, advertised aphasia treatments and products were also not used or 
recommended by a majority of respondents.  The majority of non-evidence based 
treatments for aphasia are primarily implemented by clinicians practicing 10 years or 
more.  
 
Primary Sources of Information 
Research Question 2 asked “Where are clinicians obtaining information regarding 
the practices they are implementing?”  The most frequently reported source of 
information was professional journals, which may reflect clinicians’ desire to remain 
current with the literature and to incorporate evidence-based treatments into clinical 
practices.  The second most frequently reported source of information was graduate 
school.  This may reflect the slow moving evolution of clinical practices of aphasia 
treatment as the majority of respondents had 10 or more years of clinical experience and, 
therefore, were assumed to have been out of graduate school for at least this long.  This 
may also reflect clinicians’ failure to self-evaluate and/or modify clinical practices based 
upon more current evidence.  
 Conferences were also frequently reported as a source of information regarding 
treatment approaches.  This is not surprising given the continuing education (CE) 
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requirements to maintain state and ASHA certification.  Similarly, many respondents 
reported colleagues as a primary source of information.  This would be expected as 
clinicians spend much of their professional time collaborating with colleagues and 
making recommendations to each other.  Unfortunately, fellow colleagues may not be the 
most reliable sources of evidence-based information, and clinicians should be cautious in 
employing recommended treatment approaches which have not been researched.  
 The least frequently reported sources of information were magazines and 
advertisements.  Products and treatments advertised in professional magazines and other 
SLP publications may or may not be evidence based.  Few products have endured 
rigorous clinical research to support the claims made in their testimonials.  In the current 
study, the treatment approaches with any respondent reporting “advertisement” as their 
primary means of attaining information included computer treatments and intensive 
aphasia therapy.  The treatment approaches with any respondent reporting “magazine” as 
their primary source of information included Communication Partner Training (CPT), 
Functional Communication Therapy (FCT), Promoting Aphasics’ Communicative 
Effectiveness (PACE), Semantic Feature Analysis (SFA), computer treatments, and 
Constraint-Induced Aphasia Therapy (CIAT).  In light of the fact that magazines and 
advertisements were infrequently selected as sources of information, it does not appear 
that current clinicians are relying on these sources in guiding their clinical decision-
making in aphasia treatment. 
 Several respondents also selected “other” as their primary source of obtaining 
information.  However, due to the limitations of the survey software used, no additional 
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information was able to be obtained regarding these additional sources of information.  It 
would be interesting to probe for additional information regarding what these “other” 
sources of information are and if these sources reflect EBP. 
 Because respondents cited professional journals, graduate school, and conferences 
as their primary sources of information, the dissemination of evidence-based information 
may be best achieved by capitalizing on these sources.  For example, graduate training 
programs could be designed to not only provide students with the best available scientific 
evidence but could require students to demonstrate ability to apply research to clinical 
decision-making.  As previously mentioned, the creation of ASHA’s Knowledge and 
Skills Acquisition (KASA) summary form has encouraged universities to develop 
graduate programs that meet this requirement.  
 Because many respondents indicated professional conferences as a primary source 
of clinical information, clinicians may benefit from selecting continuing education (CE) 
courses which include scientific evidence to support the therapeutic approaches 
presented.  In some situations, conferences are funded by companies whose products lack 
empirical evidence or whose presenters are biased toward products, services, or practices. 
 Therefore, ASHA provides clinicians with indicators of evidence-based CE courses.  
While participating in a course or presentation, ASHA recommends clinicians ask 
themselves several questions including 1) Is peer reviewed research provided that 
supports and/or contradicts the rationale for the course content?, 2) Where do the studies 
included in the course fall in terms of level of evidence and study quality?, and 3) Is the 
presenter combining his/her own personal expertise with the best available evidence to 
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guide the course?  Best practices suggest that clinicians appropriately match interventions 
to populations served.  Finally, it is recommended that clinicians identify which concepts 
are rooted in published evidence and which are supported by personal experiences 
(ASHA, 2009).  
 
Perceptions of Evidence 
Research Question 3 asked “Are the perceptions of what clinicians believe to be 
evidence-based in accordance with available practice guidelines?”  Based on the results 
of the survey, some evidence-based treatments for aphasia are accurately perceived as 
having considerable levels of evidence, while many other evidence-based treatments are 
not perceived as favorably.  Eight treatment approaches were perceived as having a 
moderate amount of evidence.  These treatments include Treatment for Underlying Forms 
(TUF), Semantic Feature Analysis (SFA), Spaced-Retrieval Training (SRT), Promoting 
Aphasics’ Communicative Effectiveness (PACE), Communication Partner Training 
(CPT), Constraint-Induced Aphasia Therapy (CIAT), script writing, and Anagram, Copy, 
and Recall Therapy (ACRT).  Participating, clinicians are accurate in their perception of 
these treatments as they are supported by the evidence as producing functional outcomes. 
  In contrast, many additional treatments are also supported by research but were 
not perceived as being evidence based by respondents.  For example, picture naming 
therapy, Sentence Production Program for Aphasia, Oral Reading for Language in  
Aphasia (ORLA), and Ameri-Ind were perceived as having minimal evidentiary support, 
which may underrate the value of these treatments when compared to practice guidelines.  
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 This research question may be negatively affected by the statistical phenomenon 
of regression toward the mean.  Survey research with ordinal questions, such as many 
questions included in the current survey, can be affected by regression toward the mean as 
measurements tend to be closer to the center of the distribution.  In this study, it seems as 
though respondents tended to rate treatments as having a minimal-to-moderate level of 
evidence and withheld from rating treatments as having no or strong levels of evidence.  
Regression toward the mean may help to explain why most of the treatments were rated 
near the center of the scale.  Therefore, findings must be interpreted with caution as to 
why evidence-based treatments (e.g., intensive aphasia therapy, Functional 
Communication Therapy) and treatments with limited evidence (e.g., SentenceShaper®, 
computer treatments) were all perceived as having minimal-to-moderate levels of 
evidence.  
 
Exposure Prior to Implementation 
Research Question 4 asked “How much time typically passes between when a 
clinician is first exposed to and when he/she first implements different treatment 
approaches?”  Having a better understanding of the timeline surrounding implementation 
of aphasia treatment allows us to better understand just how much exposure to an 
approach clinicians need before attempting the approach in their own practices.  Findings 
of the current study support the idea that clinicians tend to implement treatment 
approaches rather quickly after learning of its protocols and gathering the necessary 
materials.  Overall, respondents reported that they implemented almost all of the 
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treatment approaches included in the survey within “0-3 months” of learning of each 
approach.  The treatments not reported to be implemented within “0-3 months” by a 
majority of respondents were Interactive Metronome® and SentenceShaper®.  The 
participating clinicians reported varying timeframes prior to implementation for these two 
treatments.  
Although the survey asked respondents to indicate factors that have contributed to 
the lag in time between exposure and implementation, respondents were not required to 
indicate which factors corresponded with which treatments.  However, many respondents 
reported a lag in time due to the amount of time required to gather materials and the 
inability to purchase materials.  Both the Interactive Metronome® and SentenceShaper® 
are commercially available aphasia treatments which require specific materials to be 
purchased in order to implement the treatment.  Therefore, the time required to gather or 
purchase the necessary materials may have resulted in a longer lag in time between 
exposure and implementation for these two treatments, thus providing a possible 
explanation for the variability.  
 Because current findings reveal that clinicians tend to implement aphasia 
treatments within a few months of learning about them, this brings up the question of why 
are clinicians implementing approaches so quickly?  Furthermore, because it appears that 
the learning-to-implementing turnaround time occurs within three months, are clinicians 
thoroughly reviewing the evidence base prior to use?  Possible factors influencing quick 
implementation include a desire to attempt the treatment before the procedures involved 
are forgotten and excitement about a new treatment prompting implementation.  These 
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possible reasons are supported by respondents’ comments regarding interest in a new 
approach following a review of the literature indicating promise in a treatment or after 
learning of the treatment through a conference, workshop, or colleague.   
 
Factors Delaying Implementation 
Research Question 5 asked “What factors contribute to the lag in time between 
exposure to and implementation of treatment approaches?”  Findings of the current study 
fail to support an extended lag in time between exposure and implementation.  
Participating clinicians typically implemented treatments within three months of learning 
of their procedures.  However, respondents identified potential factors that could delay 
implementation.  The most frequently reported response was not having the appropriate 
client/caseload for the treatment.  This may reflect clinicians’ adherence to candidacy 
requirements for treatment approaches as they do not seem to attempt a newly learned 
approach with patients not fitting the treatment’s criteria.  Additional reasons for a lag 
between exposure and implementation identified by this study included a desire to learn 
more about the approach, a desire to review the evidence base, and a desire to ask 
colleagues’ opinions regarding the treatment.  These may reflect clinicians’ desire to 
obtain information from several sources as part of their clinical decision-making.  Despite 
the financial barriers to implementing EBP as indicated in the literature and reported by 
respondents of the current study, the least frequently reported response was not having the 
materials for the treatment.  
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Limitations of the Research 
 No research design is without limitations, and this study is no exception.  A 
common problem in survey research is a high nonresponse rate resulting in a threat to 
internal validity.  According to Schiavetti & Metz (2002), “if the nonresponse rate is high, 
the researcher may have a biased sample, a sample that may not be representative of the 
population of interest, and a sample of responders who are quite different, on important 
dimensions, from individuals who failed to respond” (p. 293).  In order to promote 
responses, researchers can implement various strategies including assuring respondent 
confidentiality and designing a short, unambiguous, and easy to complete instrument.  All 
of these measures were adopted in the present study.  
According to the ASHA 2009 Health Care Survey, “not only is it typically the 
case that some individuals who receive a survey do not complete it (unit nonresponse), it 
is likewise true that some who return theirs do not answer every question (item 
nonresponse) and thus do not qualify for inclusion in portions of a report,” (ASHA, 2009, 
p. 4).   This was the case in the current survey as many respondents selected a treatment 
approach implemented and/or recommended in the past year but did not provide 
responses to the follow up questions regarding the selected treatment.  Therefore, certain 
responses were excluded from analysis because they did not answer a question at all or 
because their answer disqualified them (e.g., providing a perceived level of evidence for a 
treatment approach that was not selected as implemented or recommended within the last 
year.)  
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 It is also important to remember that a survey instrument is only as good as the 
questions it asks.  A serious threat to internal validity is related to the adequacy of the 
survey instrument.  By pilot testing the survey instrument in the current study, revisions 
were able to be made to account for ambiguous questions, questions failing to directly 
address the issue under study, and questions leading to biased responses.   
 Although internet-based survey research has many advantages (e.g., convenience, 
ease of administration, ease of data collection), a disadvantage of internet-based research 
when compared to other descriptive research designs, such as interviews or focus groups, 
is that it is limited in the depth of information that can be obtained.  For example, a 
survey is limited in its ability to probe for more or different information based upon 
participant responses (Schiavetti & Metz, 2002).  Surveys are also limited to obtaining 
only verbal descriptions of respondents’ opinions and actions and cannot account for 
nonverbal information such as body language, eye contact, or rapport between the 
respondent and the interviewer.   
 
Future Research 
 Although ASHA and many practicing SLPs recognize the importance of EBP, the 
present study supports a research-to-practice gap in the implementation of evidence-based 
aphasia treatments and their perceived levels of evidence.  The preliminary conclusions of 
the current study extend the findings of previous surveys in the study of EBP in 
communication sciences and disorders including barriers and facilitators of EBP.  
However, we are far from having a comprehensive understanding of the attitudes and 
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perceptions of EBP held by clinicians and the role these play in clinical-decision making 
related to aphasia therapy.   
 Further investigation, including a larger sample, may prove beneficial in 
extending our understanding of the research-to-practice gap.  It is recommended that data 
be obtained regarding the “other” sources of information indicated by respondents of the 
current study and if these sources reflect EBP.  Similarly, in addition to information on 
the timeframe between exposure and implementation, our profession could benefit from 
having a better understanding of the type of exposure required.  For example, how many 
encounters with a treatment approach are required to initiate implementation?  Is a 
demonstration or observable changes in functional outcome necessary, or is simply 
reading about the approach (e.g., journal or magazine article) enough to initiate a 
clinician’s attempt at using the approach?   
 In addition to survey research, a logical next step would be obtaining descriptive 
data.  For example, as a follow-up to the current study, it is recommended that future 
studies investigate EBP via field research.  By going directly to clinical settings, 
researchers could investigate practice patterns by observing decision making.  It is 
recommended that chart data also be reviewed to document which treatments clinicians 
are using and for which patients.  Finally, focus groups may prove crucial in providing 
insight into attitude and perceptions of aphasia treatment approaches via nonverbal 
information (e.g., body language and eye contact). 
 Since ASHA’s inception of Knowledge and Skills Acquisition (KASA) in 2005, 
graduate training programs have been required to incorporate EBP into the curricula of 
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emerging clinicians.  However, the potential long-term effect(s) of a focus on EBP in 
graduate training is unknown.  It is recommended that future research probe how the 
implementation of KASA standards has impacted the perceptions of EBP in clinicians 
who have received graduate training since 2005, and whether or not these changes in 
curriculum affect their clinical practices outside of the academic arena. Furthermore, 
research could probe how the implementation of KASA standards may change clinician’s 
perceptions of EBP over time.  We have already seen that over time speech-language 
pathologists tend to rely more on personal experiences and clinical judgment than current 
research (Zipoli & Kennedy, 2005).  Perhaps clinicians who received graduate training 
since 2005 will demonstrate different patterns of reliance on current research, or they may 
rely on different sources of information as part of their clinical decision-making.  
 The field of communication sciences and disorders as a whole could benefit from 
increased use of EBP, particularly within medical speech pathology where patients’ 
quality of life is of paramount importance.  Sources such as the ASHA EBP Compendium 
and the ANCDS can provide clinicians with practice guidelines for the management of 
communication disorders in neurologically impaired individuals.  It is of the utmost 
importance that SLPs not only incorporate professional expertise but also recognize the 
role of best research evidence and patient preferences in our clinical decision-making for 
patients with aphasia.  
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Appendix A:  Web-Based and Hard Copy Survey Questions 
  
SECTION I: Demographics 
 
1. Do you currently see patients with aphasia as part of your caseload? 
a) Yes 
b) No 
 
2. If yes, approximately what percentage of your caseload consists of patients with 
aphasia? 
a) Less than 10% 
b) About 25% 
c) Between 33% - 66% 
d) About 75% 
e) More than 75% 
 
3. Please indicate the age range in which your chronological age falls: 
a) 20-30 years 
b) 31-40 years 
c) 41-50 years 
d) 51-60 years 
e) 60+ years 
 
4. Please indicate your gender: 
a) Male 
b) Female 
 
5. Do you have a current state license in Speech-Language Pathology? 
a) Yes 
b) No 
 
6. Are you a member of any ASHA Special Interest Division?   (Circle all that apply): 
a) None 
b) ASHA Special Interest Division 1, Language Learning & Education 
c) ASHA Special Interest Division 2, Neurophysiology and Neurogenic Speech & 
Language Disorders 
d) ASHA Special Interest Division 3, Voice & Voice Disorders 
e) ASHA Special Interest Division 4, Fluency & Fluency Disorders 
f) ASHA Special Interest Division 5, Speech Science & Orofacial Disorders 
g) ASHA Special Interest Division 6, Hearing and Hearing Disorders: Research & 
Diagnostics 
h) ASHA Special Interest Division 7, Aural Rehabilitation & Its Instrumentation 
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Appendix A:  (Continued) 
 
i) ASHA Special Interest Division 8, Hearing Conservation & Occupational 
Audiology 
j) ASHA Special Interest Division 9, Hearing & Hearing Disorders in Childhood 
k) ASHA Special Interest Division 10, Issues in Higher Education 
l) ASHA Special Interest Division 11, Administration & Supervision 
m) ASHA Special Interest Division 12, Augmentative & Alternative Communication 
n) ASHA Special Interest Division 13, Swallowing & Swallowing Disorders 
(Dysphagia) 
o) ASHA Special Interest Division 14, Communication Disorders & Sciences in 
Culturally and Linguistically Diverse (CLD) Populations 
p) ASHA Special Interest Division 15, Gerontology 
q) ASHA Special Interest Division 16, School-Based Issues 
 
7. Do you have any specialty credentials?   (Circle all that apply): 
a) Board Certified in Neurogenics, Academy of Neurologic Communication 
Disorders & Sciences (ANCDS) 
b) Board Recognized Specialist in Child Language 
c) Board Recognized Specialist in Fluency & Fluency Disorders 
d) Board Recognized Specialist in Swallowing & Swallowing Disorders 
 
8. Highest degree earned: 
a) Master’s degree 
b) Doctoral degree 
c) Clinical doctoral degree 
d) Other (please indicate) _____________ 
 
9. How many years have you practiced as a Speech-Language Pathologist? 
a) Less than 2 years 
b) 2-5 years 
c) 6-10 years 
d) 11-15 years 
e) 16-20 years 
f) 20+ years 
 
10. How many years have you had direct clinical experience with patients with aphasia? 
a) Less than 2 years 
b) 2-5 years 
c) 6-10 years 
d) 11-15 years 
e) 16-20 years 
f) 20+ years 
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11.  Please indicate the setting in which you currently see patients with aphasia? 
a) Hospital 
b) Skilled nursing facility 
c) College / university clinic  
d) Rehabilitation center 
e) Private or group practice 
f) Home health agency 
g) Other (please specify) _____________ 
 
SECTION II: Aphasia Treatment Approaches 
 
12. Which of the following treatment approaches have you used or recommended in the 
past year? 
 
Treatment Approaches Please indicate the treatment 
approaches you have used or 
recommended in the past year 
(Check all that apply) 
Functional Communication Therapy  
Intensive Aphasia Therapy  
Semantic Feature Analysis  
Augmentative and Alternative Communication 
(e.g., Dynavox®; Say-it! SAM Communicator®) 
 
Spaced-Retrieval Training  
PACE (Promoting Aphasics’ Communicative 
Effectiveness) 
 
Picture Naming Therapy   
Constraint-Induced Aphasia Therapy  
Interactive Metronome®  
Communication Partner Training (e.g., Supported 
Conversation; Conversational Coaching) 
 
Sentactics®  
Melodic Intonation Therapy  
Sentence Production Program for Aphasia   
Treatment for Underlying Forms  
Stimulation Approach (e.g., Workbook exercises)   
Response Elaboration Training  
Computer Treatments (e.g., Parrot Software®; 
Bungalow Software®; Lingraphica®) 
 
Sentence Shaper®  
Other (please specify)  
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SECTION III: Perceived Levels of Evidence  
 
13.  How strong do you believe the evidence to be for each approach you selected in  
       Question 12? 
 
       
 
 
 
 
Treatment Approaches Rate the level of evidence for each 
approach you selected? (Please use 
the answer key provided) 
Functional Communication Therapy  
Intensive Aphasia Therapy  
Semantic Feature Analysis  
Augmentative and Alternative 
Communication (e.g., Dynavox®; Say-it! 
SAM Communicator®) 
 
Spaced-Retrieval Training  
PACE (Promoting Aphasics’ Communicative 
Effectiveness) 
 
Picture Naming Therapy   
Constraint-Induced Aphasia Therapy  
Interactive Metronome®  
Communication Partner Training (e.g., 
Supported Conversation; Conversational 
Coaching) 
 
Sentactics®  
Melodic Intonation Therapy  
Sentence Production Program for Aphasia 
(formerly HELPSS) 
 
Treatment for Underlying Forms  
Stimulation Approach (e.g., Workbook 
exercises)  
 
Response Elaboration Training  
Computer Treatments (e.g., Parrot Software®; 
Bungalow Software®; Lingraphica®) 
 
Sentence Shaper®  
Other (please specify)  
 
Answer Key  
            1 = No evidence 
            2 = Minimal evidence 
            3 = Moderate evidence  
            4 = Strong evidence 
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SECTION IV: Sources of Information 
 
14. What has been your primary means of attaining information regarding each approach? 
 
 
 
 
 
 
 
  Treatment Approaches What has been your primary means 
of attaining information for each 
approach? (Please use the answer 
key provided) 
Functional Communication Therapy  
Intensive Aphasia Therapy  
Semantic Feature Analysis  
Augmentative and Alternative 
Communication (e.g., Dynavox®; Say-it! 
SAM Communicator®) 
 
Spaced-Retrieval Training  
PACE (Promoting Aphasics’ 
Communicative Effectiveness) 
 
Picture Naming Therapy   
Constraint-Induced Aphasia Therapy  
Interactive Metronome®  
Communication Partner Training (e.g., 
Supported Conversation) 
 
Sentactics®  
Melodic Intonation Therapy  
Sentence Production Program for Aphasia 
(formerly HELPSS) 
 
Treatment for Underlying Forms  
Stimulation Approach (e.g., Workbook 
exercises)  
 
Response Elaboration Training  
Computer Treatments (e.g., Parrot 
Software®; Bungalow Software®; 
Lingraphica®) 
 
Sentence Shaper®  
Other (please specify)  
Answer Key  
      1 = I learned about it in graduate school 
      2 = I learned about it at a conference or workshop I attended 
      3 = I learned about it through an advertisement (e.g., ASHA’s Online Buyer’s Guide, magazine, catalogue) 
      4 = I learned about it in a professional magazine (e.g., Advance, Stroke Connection Magazine, The ASHA Leader) 
      5 = I learned about it in a professional journal (e.g., American Journal of Speech-Language Pathology) 
      6 = A colleague recommended it 
      7 = Other (please specify) 
109 
 
Appendix A:  (Continued) 
 
SECTION V: Exposure Prior to Use 
 
15. Looking back, how much time would you estimate passed between when you first 
learned of each approach and when you first used it in practice? 
 
     
 
 
 
Treatment Approaches Estimate how much time passed 
between when you learned and 
when you first used each approach? 
(Please use the answer key 
provided) 
Functional Communication Therapy  
Intensive Aphasia Therapy  
Semantic Feature Analysis  
Augmentative and Alternative 
Communication (e.g., Dynavox®; Say-it! 
SAM Communicator®) 
 
Spaced-Retrieval Training  
PACE (Promoting Aphasics’ Communicative 
Effectiveness) 
 
Picture Naming Therapy   
Constraint-Induced Aphasia Therapy  
Interactive Metronome®  
Communication Partner Training (e.g., 
Supported Conversation; Conversational 
Coaching) 
 
Sentactics®  
Melodic Intonation Therapy  
Sentence Production Program for Aphasia 
(formerly HELPSS) 
 
Treatment for Underlying Forms  
Stimulation Approach (e.g., Workbook 
exercises)  
 
Response Elaboration Training  
Computer Treatments (e.g., Parrot Software®; 
Bungalow Software®; Lingraphica®) 
 
Sentence Shaper®  
Other (please specify)  
Answer Key 
         1 = 0-3 months 
         2 = 4-6 months 
         3 = 6-9 months 
         4 = 9-12 months 
         5 = >12 months 
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16. What factors have contributed to the time lag between exposure to and use of 
treatment approaches?   (Circle all that apply): 
a) Did not have the appropriate client/caseload for the treatment 
b) Wanted to learn more about the procedures of the treatment 
c) Time required to gather materials necessary for the treatment 
d) Materials for the treatment could not be purchased 
e) Wanted to review the evidence base for the treatment 
f) Wanted to ask colleagues’ opinions of the treatment 
g) Other (please specify) _____________ 
  
 
SECTION VI: Implementation 
 
17. What would facilitate your increased use of evidence-based practice related to your 
treatment of patients with aphasia? (Please use the space below to provide your answer) 
 
 
 
 
 
 
 
 
 
 
 
 
18. Describe situations which prompted you to seek and implement alternative treatment 
approaches for patients with aphasia. (Please use the space below to provide your answer) 
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Appendix B: Description of Survey Treatment Approaches 
 
1. Augmentative and Alternative Communication (AAC)- Using high-tech or low-
tech communication systems in an attempt to compensate for temporary or permanent 
activity limitations and participation restrictions of persons with severe 
communication disorders.  AAC uses aided (e.g., real objects, pictures, line drawing, 
orthography) or unaided (e.g., signs, gestures, facial expressions) symbols to convey 
meaning for those with limited verbal abilities.  Some commonly used AAC systems 
for individuals with aphasia include communication books, speech generating devices 
(SGD), remnant materials, pointing, gesturing, and pantomime (Beukelman & 
Mirenda, 2005).  
 
2. Communication Partner Training (CPT)- Involves training the communication 
partner to identify behaviors that disrupt the communication and strategies for 
eliminating those behaviors.  The communication partner is trained to both 
acknowledge and reveal the competence of the individual with language impairments. 
 Examples of CPT for individuals with aphasia include supported conversation and 
conversational coaching (Murray & Clark, 2006) 
 
3. Computer Treatments- High-tech systems that provide activities for a broad range 
of linguistic and/or cognitive deficits.  Examples of computer treatments for 
individuals with aphasia include Parrot Software®, Bungalow Software®, and 
Lingraphica®.  
 
4. Constraint-Induced Aphasia Therapy (CIAT)- A high-intensity language treatment 
consisting of both forced use of verbal language and massed practice.  CIAT uses a 
series of language games requiring verbal production shaped into successive 
approximations of the target response. Nonverbal communication (e.g., pointing, 
gestures, drawing) are not included in CIAT (Cherney et al., 2008).  
 
5. Functional Communication Therapy (FCT)- Targets communication for daily life 
activities such as communication necessary to perform job duties, participate in 
desired leisure activities, and interact with family members (Murray & Clark, 2006).   
 
6. Intensive Aphasia Therapy- Therapy is provided in a more concentrated way over a 
short period of time (e.g., 10-30 hours of therapy weekly for a number of weeks). 
Increased treatment time in intensive aphasia therapy allows for increased practice 
with a broader range of communication skills. 
 
7. Interactive Metronome®- An assessment and treatment tool which attempts to 
improve the neurological processes of motor planning, sequencing, and processing.  
IM uses a computer-generated reference tone and requires the user to match the 
rhythmic beat with repetitive motor actions (www.interactivemetronome.com)   
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8. Melodic Intonation Therapy (MIT)- A stimulation treatment for clients with severe 
nonfluent aphasia in which the user progresses from producing words and phrases in a 
rhythmic manner (like singing) to producing these words with natural prosody 
(Murray & Clark, 2006).  
 
9. Picture .aming Therapy- Used for word-finding difficulties and training semantic 
classification, PNT requires users to name a picture on a given stimulus item (e.g., 
photo card).  Places little demand on the client’s working memory and allows for 
control over the patient’s utterance to that of the picture (LaPoint, 1997).  
 
10. Promoting Aphasics’ Communicative Effectiveness (PACE)- Using cards with 
information printed on one side and placed face down on a table, the clinician and the 
client take turns selecting a card and attempting to communicate the content of the 
card to the other person.  Allows the client to practice applying compensatory 
strategies in a communication interaction (Murray & Clark, 2006).  
 
11. Response Elaboration Training (RET)- A stimulation approach for clients with 
nonfluent aphasia that involves reinforcement of client-initiated output, incidental 
learning, and emphasis on utterance content.  The clinician does not directly correct 
the patient’s spontaneous utterances but provides indirect feedback via conversational 
modeling (Murray & Clark, 2006).  
 
12. Semantic Feature Analysis (SFA)- Attempts to activate the semantic network by 
using a chart to help patients generate words that are semantically related to the target. 
 Clients are asked to name a picture as well as identify semantically related features 
(e.g., use, location, action) (Murray & Clark, 2006).  
 
13. Sentactics®- A computer-based treatment designed to improve sentence 
comprehension and production in patients with Broca’s aphasia and agrammatism.  
Attempts to train client with aphasia how to build a complex sentence from its simple 
canonical form (www.bltek.com).  
 
14. Sentence Production Program for Aphasia (SPPA)- Formerly known as the Helm 
Elicited Program for Syntax Stimulation (HELPSS), SPPA trains the production of a 
hierarchy of sentence constructions (i.e.., imperative intransitive, imperative 
transitive, Wh- interrogative, declarative transitive, declarative intransitive, 
comparative, passive, yes/no questions, direct and indirect object, embedded sentence, 
and future).  Trains sentence production at two levels: Level A, which elicits delayed 
imitation, and Level B, which elicits spontaneous response (Murray & Clark, 2006). 
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15. Sentence Shaper®- A software program which uses pictures and prompts to elicit 
spoken productions.  The user can record words or phrases and build them into 
sentences by manipulating icons on a computer screen (www.sentenceshaper.com).   
 
16. Spaced-Retrieval Training (SR)- Requires the user to practice the recall of 
information over progressively longer periods of time.  For example, the client may 
be asked to recall a piece of information after a set amount of time.  If recalled 
accurately, the time is doubled.  If recalled incorrectly or not recalled, the time is 
reduced.  Using this shaping procedure, the client can acquire and recall trained 
information with little effort but generalization to untrained tasks is not expected 
(Murray & Clark, 2006).  
 
17. Stimulation Approach- Emphasizes the underlying stimulus factors that may 
enhance/impede a client’s linguistic abilities by exposing the client to task hierarchies 
that attempt to stimulate language functioning.  Stimulation approach for aphasia 
therapy often includes workbook exercises (Murray & Clark, 2006). 
 
18. Treatment for Underlying Forms (TUFF)- Previously referred to as Linguistic 
Specific Treatment, TUFF targets syntactically complex sentence types in an attempt 
to remediate the client’s ability to process phrase movement.  TUFF is based on 
Noam Chomsky’s government binding theory and the idea that individuals with 
agrammatism have difficulty processing grammatically complex sentences (Murray & 
Clark, 2006). 
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Appendix C:  Recruitment E-Mail 
 
 
 
 
 
 
 
 
 
 
Dear Colleague, 
 
You are invited to participate in a survey study regarding approaches to aphasia therapy.  
We hope that the results of this survey will help us to understand how clinicians use 
evidence-based practice in their clinical decision making.  
 
You may access the survey at:  
http://www.c21te.usf.edu/survey/TakeSurvey.aspx?SurveyID=l4LJn62 
 
The survey will take you approximately 10 minutes.   
 
Thank you for your time and participation in this study.  If you have any questions about 
this study, please contact Erin Rowe at erowe@mail.usf.edu. 
 
 
Erin Rowe 
Graduate Clinician of Speech-Language Pathology 
University of South Florida   
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Appendix D:  Invitation to Participate and Informed Consent 
 
 
  
 
 
 
 
 
 
Informed Consent to Participate in Research  
IRB Study # _______________ 
 
 
  
 
We are asking you to take part in a research study that is called:  
Clinical Decision-Making in Aphasia Therapy: A Survey of Perceived Levels of Evidence 
for Common Treatment Approaches 
 
 
 
 
 
Purpose of the study 
The purpose of this survey is to investigate clinical decision-making in aphasia treatment. 
 We hope that the results of this survey will help us to understand how clinicians use 
evidence-based practice in their practice.  
 
The survey will take you approximately 10 minutes.  You are free to discontinue the 
survey at any time.  The survey is anonymous.  Your responses to this survey will be 
reported in grouped data.  
 
 
 
Questions, concerns, or complaints 
If you have any questions, concerns or complaints about this study, call Erin T. Rowe at 
(941) 773-5300.   
 
 
Consent to Take Part in this Research Study 
Participation is optional.  By initiating the survey, you are agreeing to participate in 
research.  Thank you for your participation. 
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Appendix E:  Survey Results Raw Data 
 
Table 23. Raw Data for Number of Responses 
 
Total Responses N = 117 
Excluded (Do Not Treat Aphasia) N = 8 
Excluded (Did Not Complete Survey) N = 5 
Total Responses for Analysis  . = 104 
 
SECTION I: Demographics 
 
Table 24. Raw Data for Survey Question 1 
Do you currently see patients with aphasia as part of your caseload? 
  
  
 
 
 
Table 25. Raw Data for Survey Question 2 
Approximately what percentage of your caseload consists of patients with aphasia? 
 
Response . % 
Less than 10% 17 16.34% 
About 25% 26 25.00% 
Between 33% - 66% 28 26.92% 
About 75% 9 8.65% 
More than 75% 24 23.07% 
 
Table 26. Raw Data for Survey Question 3 
Please indicate the age range in which your chronological age falls 
 
Response . % 
20-30 years 11 10.57% 
31-40 years 14 13.46% 
41-50 years 37 35.57% 
51-60 years 34 32.69% 
60+ years 8 7.69% 
 
 
 
 
Response . % 
Yes 109 93.16% 
No 8 6.83% 
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Table 27. Raw Data for Survey Question 4 
Please indicate your gender 
Response . % 
Male 8 7.69% 
Female 96 92.30% 
 
Table 28. Raw Data for Survey Question 5 
Do you have a current state license in Speech-Language Pathology? 
 
Response . % 
Yes 97 93.26% 
No 7 6.73% 
 
Table 29. Raw data for Survey Question 6 
Are you a member of any ASHA Special Interest Division? 
 
SID . % 
ASHA SID 1, Language Learning & Education 2 1.92% 
ASHA SID 2, Neurophysiology & Neurogenic Speech & Lang Dis 80 76.92% 
ASHA SID 3, Voice & Voice Dis 10 9.61% 
ASHA SID 4, Fluency & Fluency Dis 2 1.92% 
ASHA SID 5, Speech Science & Orofacial Dis 1 0.96% 
ASHA SID 6, Hearing & Hearing Dis: Research & Diagnostics 0 0% 
ASHA SID 7, Aural Rehabilitation & Its Instrumentation 0 0% 
ASHA SID 8, Hearing Conservation & Occupational Audiology 0 0% 
ASHA SID 9, Hearing & Hearing Dis in Childhood 0 0% 
ASHA SID 10, Issues in Higher Education 6 5.76% 
ASHA SID 11, Administration & Supervision 12 11.53% 
ASHA SID 12, Augmentative & Alternative Communication 9 8.65% 
ASHA SID 13, Swallowing & Swallowing Dis  29 27.88% 
ASHA SID 14, CSD in Culturally & Linguistically Diverse Pop 4 3.84% 
ASHA SID 15, Gerontology 13 12.50% 
ASHA SID 16, School-Based Issues 2 1.92% 
None 16 15.38% 
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Table 30. Raw Data for Survey Question 7 
Do you have any specialty credentials? 
 
Response . % 
Board Certified in Neurogenics, (ANCDS) 9 8.65% 
Board Recognized Specialist in Child Language 0 0% 
Board Recognized Specialist in Fluency & Fluency Dis 1 0.96% 
Board Recognized Specialist in Swallowing & Swallowing Dis 1 0.96% 
None 89 85.57% 
Other 
         Certified Brain Injury Specialist 
         LSVT Certification 
         Multiple Sclerosis Certified Specialist 
 
2 
1 
1 
 
1.92% 
0.96% 
0.96% 
 
Table 31. Raw Data for Survey Question 8 
Highest degree earned 
 
Response . % 
Master’s degree 74 71.15% 
Doctoral degree 27 25.95% 
Clinical doctoral degree 3 2.88% 
Other 0 0% 
 
Table 32. Raw Data for Survey Question 9 
How many years have you practiced as a Speech-Language Pathologist? 
 
Response . % 
Less than 2 years 3 2.88% 
2-5 years 14 13.46% 
6-10 years 12 11.53% 
11-15 years 16 15.38% 
16-20 years 15 14.42% 
20+ years 44 42.30% 
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Table 33. Raw Data for Survey Question 10 
How many years have you had direct clinical experience with patients with aphasia? 
 
Response . % 
Less than 2 years 3 2.88% 
2-5 years 15 14.42% 
6-10 years 16 15.38% 
11-15 years 15 14.42% 
16-20 years 14 13.46% 
20+ years 41 39.42% 
 
 
Table 34. Raw Data for Survey Question 11 
Please indicate the setting in which you currently see patients with aphasia 
 
Response . % 
Hospital 41 39.42% 
Skilled nursing facility 10 9.61% 
College / university clinic 39 37.50% 
Rehabilitation center 33 31.73% 
Private or group practice 10 9.61% 
Home health agency 4 3.84% 
Other 0 0% 
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SECTION II: Aphasia Treatment Approaches 
 
Table 35. Raw Data for Survey Question 12 
Which of the following treatment approaches have you used/recommended in past year? 
 
Treatment Approaches . % 
Communication Partner Training (CPT) 74 71.15% 
Functional Communication Therapy (FCT) 72 69.23% 
Promoting Aphasics’ Communicative Effectiveness (PACE) 70 67.30% 
Augmentative and Alternative Communication (AAC) 65 62.50% 
Stimulation Approach  59 56.73% 
Melodic Intonation Therapy (MIT) 55 52.88% 
Semantic Feature Analysis (SFA) 53 50.96% 
Picture Naming Therapy  45 43.26% 
Computer Treatments 40 38.46% 
Intensive Aphasia Therapy 40 38.46% 
Response Elaboration Training (RET) 33 31.73% 
Sentence Production Program for Aphasia 31 29.80% 
Spaced-Retrieval Training (SRT) 31 29.80% 
Constraint-Induced Aphasia Therapy (CIAT) 24 23.07% 
Treatment for Underlying Forms (TUF) 12 11.53% 
Interactive Metronome® (IM) 5 4.80% 
Sentence Shaper® (SSR) 5 4.80% 
Sentactics® 2 1.92% 
 Anagram, Copy, and Recall Therapy (ACRT/CART) 7 6.73% 
Oral Reading for Language in Aphasia (ORLA) 4 3.84% 
Amer-Ind 2 1.92% 
Scripts 2 1.92% 
Book Connection™       1 0.96% 
Cognitive-Linguistic Approaches 1 0.96% 
Cognitive Underpinnings 1 0.96% 
Cued Verb Treatment 1 0.96% 
English as a Second Language (ESL) Websites 1 0.96% 
Fluent Generative Naming 1 0.96% 
Gesture and Verbal Training (GVT) 1 0.96% 
Mapping 1 0.96% 
Multiple Oral Re-reading (MOR) 1 0.96% 
Phonological Components Analysis (PCA)  1 0.96% 
Picture Communication Boards 1 0.96% 
Problem-Solving Approach to Spelling 1 0.96% 
Repetition Priming 1 0.96% 
Semantic Phonetic Cueing Hierarchy 1 0.96% 
Simply Smart Aphasia Therapy (SSAT)  1 0.96% 
Treatment of Aphasic Perseveration (TAPS) 1 0.96% 
Visual Action Therapy (VAT) 1 0.96% 
Verb Network Strengthening Treatment (VNeST) 1 0.96% 
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SECTION III:  Perceived Levels of Evidence 
 
Table 36. Raw Data for Survey Question 13 
How strong do you believe the evidence to be for each approach you selected? 
 
Table 36-A. Communication Partner Training 
Response ./36 % 
No evidence 1 1.58% 
Minimal evidence 15 23.80% 
Moderate evidence 32 50.79% 
Strong evidence 15 23.80% 
 
Table 36-B. Functional Communication Therapy 
Response ./63 % 
No evidence 1 1.58% 
Minimal evidence 25 39.68% 
Moderate evidence 27 42.85% 
Strong evidence 10 15.87% 
 
Table 36-C. Promoting Aphasics’ Communicative Effectiveness 
Response ./48 % 
No evidence 0 0% 
Minimal evidence 17 35.41% 
Moderate evidence 25 52.08% 
Strong evidence 6 12.50% 
 
Table 36-D. Augmentative and Alternative Communication 
Response ./53 % 
No evidence 0 0% 
Minimal evidence 24 45.28% 
Moderate evidence 21 39.62% 
Strong evidence 8 15.09% 
 
Table 36-E. Stimulation Approach 
Response ./41 % 
No evidence 5 12.19% 
Minimal evidence 23 56.09% 
Moderate evidence 13 31.70% 
Strong evidence 0 0% 
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Table 36-F. Melodic Intonation Therapy 
Response ./44 % 
No evidence 0 0% 
Minimal evidence 21 47.72% 
Moderate evidence 18 40.90% 
Strong evidence 5 11.36% 
 
Table 36-G. Semantic Feature Analysis 
Response ./46 % 
No evidence 0 0% 
Minimal evidence 8 17.39% 
Moderate evidence 34 73.91% 
Strong evidence 4 8.69% 
 
Table 36-H. Picture Naming Therapy 
Response ./36 % 
No evidence 0 0% 
Minimal evidence 18 50.00% 
Moderate evidence 15 41.66% 
Strong evidence 3 8.33% 
 
Table 36-I. Computer Treatments 
Response ./30 % 
No evidence 2 6.66% 
Minimal evidence 13 43.33% 
Moderate evidence 13 43.33% 
Strong evidence 2 6.66% 
 
 
Table 36-J. Intensive Aphasia Therapy 
Response ./54 % 
No evidence 0 0% 
Minimal evidence 16 29.62% 
Moderate evidence 23 42.59% 
Strong evidence 15 27.77% 
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Table 36-K. Response Elaboration Training 
Response ./25 % 
No evidence 1 4.00% 
Minimal evidence 10 40.00% 
Moderate evidence 9 36.00% 
Strong evidence 5 20.00% 
 
Table 36-L. Sentence Production Program for Aphasia 
Response ./26 % 
No evidence 3 11.53% 
Minimal evidence 13 50.00% 
Moderate evidence 8 30.76% 
Strong evidence 2 7.69% 
 
Table 36-M. Spaced-Retrieval Training 
Response ./26 % 
No evidence 0 0% 
Minimal evidence 9 34.61% 
Moderate evidence 15 57.69% 
Strong evidence 2 7.69% 
 
Table 36-N. Constraint-Induced Aphasia Therapy 
Response ./16 % 
No evidence 0 0% 
Minimal evidence 4 25.00% 
Moderate evidence 8 50.00% 
Strong evidence 4 25.00% 
 
Table 36-O. Treatment for Underlying Forms 
Response ./11 % 
No evidence 0 0% 
Minimal evidence 1 9.09% 
Moderate evidence 9 81.81% 
Strong evidence 1 9.09% 
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Table 36-P. Interactive Metronome 
Response ./2 % 
No evidence 0 0% 
Minimal evidence 0 0% 
Moderate evidence 0 0% 
Strong evidence 2 100% 
 
Table 36-Q. Sentence Shaper 
Response ./4 % 
No evidence 0 0% 
Minimal evidence 2 50.00% 
Moderate evidence 2 50.00% 
Strong evidence 0 0% 
 
Table 36-R. Sentactics 
Response ./2 % 
No evidence 1 50% 
Minimal evidence 0 0% 
Moderate evidence 1 50% 
Strong evidence 0 0% 
 
Table 36-S. Anagram, Copy, and Recall Therapy 
Response ./6 % 
No evidence 0 0% 
Minimal evidence 2 33.33% 
Moderate evidence 3 50.00% 
Strong evidence 1 16.66% 
 
Table 36-T. Oral Reading for Language in Aphasia 
Response ./4 % 
No evidence 0 0% 
Minimal evidence 2 50.00% 
Moderate evidence 1 25.00% 
Strong evidence 1 25.00% 
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Table 36-U. Amer-Ind 
Response ./1 % 
No evidence 0 0% 
Minimal evidence 1 100.00% 
Moderate evidence 0 0% 
Strong evidence 0 0% 
 
Table 36-V. Scripts 
Response ./2 % 
No evidence 0 0% 
Minimal evidence 0 0% 
Moderate evidence 2 100.00% 
Strong evidence 0 0% 
 
Table 36-W. Treatment Approaches Perceived as Having “Minimal” Evidence 
Treatment Approaches Rated  
“Minimal Evidence” 
% of Respondents Rating 
“Minimal Evidence” 
Stimulation Approach 56.09% 
Picture Naming Therapy 50.00% 
Sentence Production Program for Aphasia 50.00% 
Other 
         Oral Reading for Language in Aphasia (ORLA) 
         Amer-Ind 
 
50.00% 
100.00% 
 
Table 36-X. Treatment Approaches in Perceived as Having “Moderate” Evidence 
Treatment Approaches Rated  
“Moderate Evidence” 
% of Respondents Rating 
“Moderate Evidence” 
Treatment for Underlying Forms (TUF) 81.81% 
Semantic Feature Analysis (SFA) 73.91% 
Spaced-Retrieval Training (SRT) 57.69% 
Promoting Aphasics’ Communicative Effectiveness 
(PACE) 
52.08% 
Communication Partner Training (CPT) 50.79% 
Constraint-Induced Aphasia Therapy (CIAT) 50.00% 
Other 
         Scripts 
         Anagram, Copy, & Recall Therapy (ACRT/CART) 
 
100.00% 
50.00% 
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SECTION IV:  Sources of Information 
 
Table 37. Raw Data for Survey Question 14 
What has been your primary means of attaining information regarding each approach? 
 
Table 37-A. Communication Partner Training 
Response ./62 % 
Grad School 6 9.67% 
Conference 17 27.41% 
Advertisement 0 0% 
Magazine 2 3.22% 
Journal 23 37.09% 
Colleague 11 17.74% 
Other 3 4.83% 
 
Table 37-B. Functional Communication Therapy 
Response ./60 % 
Grad School 16 26.66% 
Conference 14 23.33% 
Advertisement 0 0% 
Magazine 2 3.33% 
Journal 18 30.00% 
Colleague 6 10.00% 
Other 4 6.66% 
 
Table 37-C. Promoting Aphasics’ Communicative Effectiveness 
Response ./46 % 
Grad School 22 47.82% 
Conference 6 13.04% 
Advertisement 0 0% 
Magazine 1 2.17% 
Journal 11 23.91% 
Colleague 5 10.86% 
Other 1 2.17% 
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Table 37-D. Augmentative and Alternative Communication 
Response ./53 % 
Grad School 17 32.07% 
Conference 16 30.18% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 7 13.20% 
Colleague 8 15.09% 
Other 5 9.43% 
 
Table 37-E. Stimulation Approach 
Response ./44 % 
Grad School 31 70.45% 
Conference 1 2.27% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 4 9.09% 
Colleague 5 11.36% 
Other 3 6.81% 
 
Table 37-F. Melodic Intonation Therapy 
Response ./45 % 
Grad School 24 53.33% 
Conference 2 4.44% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 15 33.33% 
Colleague 2 4.44% 
Other 2 4.44% 
 
Table 37-G. Semantic Feature Analysis 
Response ./45 % 
Grad School 9 20.00% 
Conference 3 6.66% 
Advertisement 0 0% 
Magazine 2 4.44% 
Journal 25 55.55% 
Colleague 4 8.88% 
Other 2 4.44% 
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Table 37-H. Picture Naming Therapy 
Response ./32 % 
Grad School 21 65.62% 
Conference 3 9.37% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 5 15.62% 
Colleague 3 9.37% 
Other 0 0% 
 
Table 37-I. Computer Treatments 
Response ./32 % 
Grad School 1 3.12% 
Conference 7 21.87% 
Advertisement 3 9.37% 
Magazine 1 3.12% 
Journal 4 12.50% 
Colleague 7 21.87% 
Other 9 28.12% 
 
Table 37-J. Intensive Aphasia Therapy 
Response ./32 % 
Grad School 9 28.12% 
Conference 2 6.25% 
Advertisement 1 3.12% 
Magazine 0 0% 
Journal 12 37.50% 
Colleague 6 18.75% 
Other 2 6.25% 
 
Table 37-K. Response Elaboration Training 
Response ./25 % 
Grad School 5 20.00% 
Conference 2 8.00% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 12 48.00% 
Colleague 5 20.00% 
Other 1 4.00% 
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Table 37-L. Sentence Production Program for Aphasia 
Response ./24 % 
Grad School 8 33.33% 
Conference 1 4.16% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 8 33.33% 
Colleague 4 16.66% 
Other 3 12.50% 
 
Table 37-M. Spaced-Retrieval Training 
Response ./25 % 
Grad School 3 12.00% 
Conference 6 24.00% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 12 48.00% 
Colleague 3 12.00% 
Other 1 4.00% 
 
Table 37-N. Constraint-Induced Aphasia Therapy 
Response ./16 % 
Grad School 2 12.50% 
Conference 5 31.25% 
Advertisement 0 0% 
Magazine 1 6.25% 
Journal 8 50.00% 
Colleague 0 0% 
Other 0 0% 
 
Table 37-O. Treatment for Underlying Forms 
Response ./12 % 
Grad School 0 0% 
Conference 1 8.33% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 10 83.33% 
Colleague 0 0% 
Other 1 8.33% 
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Table 37-P. Interactive Metronome 
Response ./2 % 
Grad School 0 0% 
Conference 1 50.00% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 0 0% 
Colleague 1 50.00% 
Other 0 0% 
 
Table 37-Q. Sentence Shaper 
Response ./4 % 
Grad School 0 0% 
Conference 0 0% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 2 50.00% 
Colleague 1 25.00% 
Other 1 25.00% 
 
Table 37-R. Sentactics 
Response ./1 % 
Grad School 0 0% 
Conference 0 0% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 0 0% 
Colleague 1 100% 
Other 0 0% 
 
Table 37-S. Anagram, Copy, and Recall Therapy 
Response ./4 % 
Grad School 0 0% 
Conference 0 0% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 2 50.00% 
Colleague 1 25.00% 
Other 1 25.00% 
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Table 37-T. Oral Reading for Language in Aphasia 
Response ./4 % 
Grad School 0 0% 
Conference 1 25.00% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 1 25.00% 
Colleague 2 50.00% 
Other 0 0% 
 
Table 37-U. Amer-Ind 
Response ./0 % 
Grad School 0 0% 
Conference 0 0% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 0 0% 
Colleague 0 0% 
Other 0 0% 
 
Table 37-V. Scripts 
Response ./2 % 
Grad School 0 0% 
Conference 0 0% 
Advertisement 0 0% 
Magazine 0 0% 
Journal 1 50.00% 
Colleague 1 50.00% 
Other 0 0% 
 
Table 37-W. Treatment Approaches Learned in Graduate School 
Treatment Approaches Reported to be 
Learned In “Graduate School” 
% of Respondents Selecting 
“Graduate School” As Primary 
Source of Information 
Stimulation Approach 70.45% 
Picture Naming Therapy 65.62% 
Melodic Intonation Therapy (MIT) 53.33% 
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Table 37-X. Treatment Approaches Learned in Professional Journals 
Treatment Approaches Reported to be 
Learned In “Professional Journal” 
% of Respondents Selecting 
“Professional Journal” As Primary 
Source of Information 
Treatment For Underlying Forms (TUF) 83.33% 
Semantic Feature Analysis (SFA) 55.55% 
Constraint-Induced Aphasia Therapy (CIAT) 50.00% 
Sentence Shaper 50.00% 
Other 
        Anagram, Copy, and Recall Therapy 
(ACRT/CART) 
        Scripts 
 
50.00% 
50.00% 
 
Table 37-Y. Overall Frequency of Sources Reported 
Source of Information . % of Respondents 
Professional Journal 180 31.57% 
Graduate School 174 30.52% 
Conference 88 15.43% 
Colleague 76 13.33% 
Other 39 6.84% 
Magazine 9 1.57% 
Advertisement 4 0.70% 
 
SECTION V:  Exposure Prior to Use 
 
Table 38. Raw Data for Survey Question 15 
Looking back, how much time would you estimate passed between when you first 
learned of each approach and when you first used it in practice? 
 
Table 38-A. Communication Partner Training 
Response ./57 % 
0-3 Months 36 63.15% 
4-6 Months 10 17.54% 
6-9 Months 4 7.01% 
9-12 Months 4 7.01% 
>12 Months 3 5.26% 
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Table 38-B. Functional Communication Therapy 
Response ./54 % 
0-3 Months 40 74.07% 
4-6 Months 2 3.70% 
6-9 Months 2 3.70% 
9-12 Months 4 7.40% 
>12 Months 6 11.11% 
 
Table 38-C. Promoting Aphasics’ Communicative Effectiveness 
Response ./40 % 
0-3 Months 24 60.00% 
4-6 Months 8 20.00% 
6-9 Months 2 5.00% 
9-12 Months 2 5.00% 
>12 Months 4 10.00% 
 
Table 38-D. Augmentative and Alternative Communication 
Response ./49 % 
0-3 Months 24 48.97% 
4-6 Months 4 8.16% 
6-9 Months 7 14.28% 
9-12 Months 5 10.20% 
>12 Months 9 18.36% 
 
Table 38-E. Stimulation Approach 
Response ./40 % 
0-3 Months 32 80.00% 
4-6 Months 3 7.50% 
6-9 Months 2 5.00% 
9-12 Months 1 2.50% 
>12 Months 2 5.00% 
 
Table 38-F. Melodic Intonation Therapy 
Response ./38 % 
0-3 Months 15 39.47% 
4-6 Months 5 13.15% 
6-9 Months 6 15.78% 
9-12 Months 2 5.26% 
>12 Months 10 26.31% 
 
134 
 
Appendix E: (Continued) 
 
Table 38-G. Semantic Feature Analysis 
Response ./38 % 
0-3 Months 23 60.52% 
4-6 Months 7 18.42% 
6-9 Months 4 10.52% 
9-12 Months 2 5.26% 
>12 Months 2 5.26% 
 
Table 38-H. Picture Naming Therapy 
Response ./26 % 
0-3 Months 22 84.61% 
4-6 Months 1 3.84% 
6-9 Months 0 0% 
9-12 Months 1 3.84% 
>12 Months 2 7.69% 
 
Table 38-I. Computer Treatments 
Response ./28 % 
0-3 Months 17 60.71% 
4-6 Months 5 17.85% 
6-9 Months 2 7.14% 
9-12 Months 0 0% 
>12 Months 4 14.28% 
 
Table 38-J. Intensive Aphasia Therapy 
Response ./27 % 
0-3 Months 13 48.14% 
4-6 Months 5 18.51% 
6-9 Months 0 0% 
9-12 Months 1 3.70% 
>12 Months 8 29.62% 
 
Table 38-K. Response Elaboration Training 
Response ./24 % 
0-3 Months 12 50.00% 
4-6 Months 5 20.83% 
6-9 Months 2 8.33% 
9-12 Months 2 8.33% 
>12 Months 3 12.50% 
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Table 38-L. Sentence Production Program for Aphasia 
Response ./21 % 
0-3 Months 12 57.14% 
4-6 Months 1 4.76% 
6-9 Months 2 9.52% 
9-12 Months 2 9.52% 
>12 Months 4 19.04% 
 
Table 38-M. Spaced-Retrieval Training 
Response ./22 % 
0-3 Months 13 59.09% 
4-6 Months 4 18.18% 
6-9 Months 0 0% 
9-12 Months 3 13.63% 
>12 Months 2 9.09% 
 
Table 38-N. Constraint-Induced Aphasia Therapy 
Response ./13 % 
0-3 Months 8 61.53% 
4-6 Months 2 15.38% 
6-9 Months 1 7.69% 
9-12 Months 1 7.69% 
>12 Months 1 7.69% 
 
Table 38-O. Treatment for Underlying Forms 
Response ./10 % 
0-3 Months 3 30.00% 
4-6 Months 2 20.00% 
6-9 Months 1 10.00% 
9-12 Months 2 20.00% 
>12 Months 2 20.00% 
 
Table 38-P. Interactive Metronome 
Response ./2 % 
0-3 Months 0 0% 
4-6 Months 1 50.00% 
6-9 Months 1 50.00% 
9-12 Months 0 0% 
>12 Months 0 0% 
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Table 38-Q. Sentence Shaper 
Response ./3 % 
0-3 Months 0 0% 
4-6 Months 1 33.33% 
6-9 Months 0 0% 
9-12 Months 1 33.33% 
>12 Months 1 33.33% 
 
Table 38-R. Sentactics 
Response ./2 % 
0-3 Months 1 50.00% 
4-6 Months 0 0% 
6-9 Months 0 0% 
9-12 Months 0 0% 
>12 Months 1 50.00% 
 
Table 38-S. Anagram, Copy, and Recall Therapy 
Response ./3 % 
0-3 Months 3 100% 
4-6 Months 0 0% 
6-9 Months 0 0% 
9-12 Months 0 0% 
>12 Months 0 0% 
 
Table 38-T. Oral Reading for Language in Aphasia 
Response ./3 % 
0-3 Months 3 100% 
4-6 Months 0 0% 
6-9 Months 0 0% 
9-12 Months 0 0% 
>12 Months 0 0% 
 
Table 38-U. Amer-Ind 
Response ./0 % 
0-3 Months 0 0% 
4-6 Months 0 0% 
6-9 Months 0 0% 
9-12 Months 0 0% 
>12 Months 0 0% 
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Table 38-V. Scripts 
Response ./1 % 
0-3 Months 1 100% 
4-6 Months 0 0% 
6-9 Months 0 0% 
9-12 Months 0 0% 
>12 Months 0 0% 
 
Table 38-W. Treatment Approaches Implemented Within Three Months of Exposure 
Treatment Approaches Reported to be 
Implemented Within “0-3 Months” of Learning 
% of Respondents Selecting 
“0-3 Months” 
Picture Naming Therapy 84.61% 
Stimulation Approach 80.00% 
Functional Communication Therapy (FCT) 74.07% 
Communication Partner Training (CPT) 63.15% 
Constraint-Induced Aphasia Therapy (CIAT) 61.53% 
Computer Treatments 60.71% 
Semantic Feature Analysis (SFA) 60.52% 
Promoting Aphasics’ Communicative Effectiveness 
(PACE) 
60.00% 
Spaced-Retrieval Training (SRT) 59.09% 
Sentence Production Program for Aphasia 57.14% 
Response Elaboration Training (RET) 50.00% 
Sentactics 50.00% 
 
Table 39. Raw Data for Survey Question 16 
What factors have contributed to the time lag between exposure to and use of treatment 
approaches? 
Response n % 
Did not have the appropriate client/caseload for the 
treatment 
62 59.61% 
Wanted to learn more about the procedures of the treatment 36 34.61% 
Wanted to review the evidence base for the treatment 28 26.92% 
Time required to gather materials necessary for the 
treatment 
27 25.96% 
Wanted to ask colleagues’ opinions of the treatment 21 20.19% 
Materials for the treatment could not be purchased 14 13.46% 
Other 0 0% 
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SECTION VI: Implementation 
 
Table 40. Raw Data for Survey Question 17 
What would facilitate your increased use of evidence-based practice related to your 
treatment of patients with aphasia? 
 
Trend Category Comments Identified % of Comments 
Increased ease of access to 
information 
36 45.00% 
Need for practice-based information 23 28.75% 
Allocation of financial resources 8 10.00% 
Lack of time 7 8.75% 
Non-codable/Irrelevant 6 7.50% 
 
Table 41. Raw Data for Survey Question 18 
Describe situations which prompted you to seek and implement alternative treatment 
approaches for patients with aphasia. 
 
Trend Category Comments Identified % of Comments 
Lack of treatment success 28 36.8% 
Client need 19 25.0% 
Challenging diagnoses 13 17.1% 
Interest in a new treatment approach 5 6.6% 
Clinician expertise 5 6.6% 
Non-codable/Irrelevant 6 7.9% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
